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Abstract	
Biofabrication	holds	the	potential	 to	generate	constructs	that	more	closely	recapitulate	the	complexity	
and	heterogeneity	of	tissues	and	organs	than	currently	available	regenerative	medicine	therapies.	Such	
constructs	 can	be	applied	 for	 the	 regeneration	of	 tissues	or	as	 in	 vitro	 3D	models.	As	biofabrication	 is	
maturing	and	growing,	scientists	with	different	backgrounds	are	joining	this	field,	underscoring	the	need	
for	unity	regarding	the	use	of	terminology.	Hence,	we	believe	there	 is	a	compelling	need	to	clarify	 the	
relationship	between	different	concepts,	 technologies,	and	description	of	biofabrication	 that	are	often	
used	interchangeably	and/or	mixed	in	the	current	literature.	In	doing	so,	we	propose	the	introduction	of	
a	 comparative	 tool	 to	 address	 currently	 established	 biofabrication	 technologies	 in	 terms	 of	 balance	
between	resolution	and	speed	of	fabrication.	Our	objective	is	to	provide	a	guide	on	the	terminology	used	
to	 identify	 different	 technologies	 in	 the	 field,	 which	 can	 serve	 as	 guidance	 for	 the	 biofabrication	
community.	
	
What	do	we	mean	by	biofabrication?			
Biofabrication	combines	principles	of	engineering,	biology,	and	material	science	and	holds	the	promise	
to	 change	 the	 toolbox	 for	 many	 biotechnological	 disciplines.	 Recently,	 in	 the	 context	 of	 tissue	
engineering	and	regenerative	medicine	applications,	 the	definition	of	biofabrication	as	a	 research	 field	
was	 updated	 as	 “the	 automated	 generation	 of	 biologically	 functional	 products	 with	 structural	
organization	from	living	cells,	bioactive	molecules,	biomaterials,	cell	aggregates	such	as	micro-tissues,	or	
hybrid	 cell-material	 constructs,	 through	 bioprinting	 or	 bioassembly	 and	 subsequent	 tissue	 maturation	
processes.”	[1].	This	definition	includes	the	fabrication	of	scaffolds	with	hierarchical	structural	properties	
or	 smart	 surface	 properties	 within	 the	 realm	 of	 bioprinting.	 It	 was	 reasoned	 that	 the	 design	 of	 such	
features	 would	 be	 indispensable	 to	 obtain	 structurally	 functional	 biological	 substitutes.	 This	 work	
provided	an	overview	of	the	historical	evolution	and	broader	meaning	of	the	term,	and	also	specified	the	
research	 field	 with	 a	 focus	 on	 applications	 in	 tissue	 engineering	 and	 regenerative	 medicine,	 and	
proposed	 bioprinting	 and	 bioassembly	 as	 the	 two	 major	 approaches	 to	 biofabrication.	 Despite	 this	
definition	and	positioning	of	the	field,	as	well	as	recent	reviews	that	nicely	provide	a	common	framework	
to	 the	additive	manufacturing	 field	at	 large	 [2-5],	 the	 terminology	commonly	used	especially	 in	 recent	
literature	is	not	clearly	defined	and	lacks	consensus.	This	absence	of	an	agreed	and	accepted	terminology	
can	and	partially	already	does	lead	to	uncertainty	or	confusion	in	the	description	of	new	approaches	and	
possible	 misunderstanding	 as	 to	 where	 a	 new	 report	 fits	 in	 relation	 to	 previous	 reports.	 This	 could	
impede	the	development	of	the	field	by	making	it	difficult	to	correctly	map	progress	in	the	science	and	
technology	of	biofabrication.	
Here,	 we	 intend	 to	 follow-up	 from	 our	 previous	 review	 updating	 the	 definition	 of	 biofabrication	 for	
tissue	 engineering	 and	 regenerative	 medicine	 applications	 [1].	 We	 want	 to	 set	 an	 overarching	
terminology	 framework	 by	 clarifying	 the	 technologies	 used	within	 biofabrication	 strategies,	 as	well	 as	
rationalising	 appropriate	 terminologies,	 as	 an	 integral	 communication	 basis	 for	 all	 the	 different	
application	 fields	 of	 biofabrication.	 We,	 therefore,	 feel	 that	 a	 brief	 review	 of	 classical	 and	 novel	
biofabrication	 approaches,	with	 the	 aim	 to	 point	 out	 the	 differences	 among	 them	and	 the	 limitations	
that	must	still	be	overcome,	is	timely.	A	glossary	of	the	main	different	terminology	clarified	in	this	article	
is	also	provided	in	this	article.	We	also	point	out	potential	future	research	directions	where	we	believe	
biofabrication	 may	 have	 a	 major	 impact,	 with	 the	 objective	 to	 collaborate	 with	 industry	 to	 bring	
biofabrication	 strategies	 to	 the	 clinic	 in	 a	 more	 efficient	 and	 consensual	 manner	 and	 to	 collectively	
overcome	future	regulatory	and	ethical	challenges.		
	
Technologies	used	for	Biofabrication		
As	 previously	 indicated,	 biofabrication	 strategies	 employed	 for	 tissue	 engineering	 and	 regenerative	
medicine	can	be	identified	as	either	bioprinting	or	bioassembly.	Such	strategies	can	be	divided	into	two	
categories:	 (i)	 scaffold-based	 and	 (ii)	 scaffold-free	 strategies.	 In	 this	 context,	 scaffold	means	 a	 three-
dimensional	 (3D)	 porous	 structure	 that	 serves	 as	 a	 support	 for	 cell	 adhesion	 and	 guides	 tissue	
regeneration.		
To	 further	 classify	 the	 various	 bioprinting	 and	 bioassembly	 technologies	 in	 terms	 of	 efficiency	 of	
fabrication,	we	introduce	the	“spatial	Resolution/Time	for	Manufacturing”	(RTM)	ratio	as	a	quantitative	
characterization	 of	 the	 process	 underlying	 a	 specific	 technology,	 considering	 the	 ability	 to	 produce	
scaffolds	with	fine	details	in	a	short	time	as	a	figure	of	merit.	RTM	is	defined	as:		
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Here,	R	is	the	best	spatial	resolution	that	can	be	achieved	within	the	technology	and	P	is	the	delivery	rate	
of	 the	 material	 being	 printed	 or	 assembled.	 R	 is	 expressed	 as	 the	 inverse	 of	 the	minimum	 feature	
dimension	“d”:	d	is	measured	in	meter,	thus	R	is	measured	in	1/meter;	P	is	expressed	as	volume	“V”	of	
material	 (measured	 in	 m
3
)	 delivered	 per	 unit	 of	 time	 “t”	 (in	 minutes).	 As	 consequence,	 the	 physical	
dimensions	of	the	RTM	ratio	are	square-length/time.	In	the	biofabrication	field,	the	order	of	magnitude	
of	R	and	P	are	1/μm	and	mm
3
/min	respectively:	hence,	the	RTM	ratio	has	to	be	expressed	in	10
-3
	m
2
/min	
for	an	easier	comparison	between	different	technologies.	Note	that,	for	each	specific	technology,	R	and	
P	may	vary,	depending	on	the	material	delivered,	as	well	as	on	the	geometry	of	the	scaffold	and	on	its	
placement	in	the	building	chamber.		
In	 the	 following	 sections,	 standard	 operating	 procedures	 are	 considered	 (such	 as	 commonly	 used	
materials,	average	printing	parameters,	single	or	multiple	material	deposition	head)	for	building	a	1	cm	
side	cube	of	material	 (=	10
-6
	m
3
),	 lying	on	one	of	 its	 faces.	Table	1	 lists	 the	average	RTM	ratios	 for	 the	
biofabrication	 technologies	 that	 will	 be	 considered	 in	 the	 present	 work.	 Figure	 1,	 Key	 Figure,	 gives	 a	
graphical	representation	of	the	distribution	of	the	various	biofabrication	technologies	 in	the	parameter	
space	with	axes	of	minimum	feature	dimension	d	and	delivery	rate	P:	as	explained	above	R	and	P	may	
vary	 for	 each	 technology,	which	 are	 represented	 by	 circles.	 In	 Figure	 1,	 the	 contour	 lines	 of	 the	 RTM	
function	 are	 also	 plotted:	 technologies	 along	 the	 same	 contour	 line	 have	 the	 same	 RTM.	 Generally	
speaking,	 the	 higher	 the	 value	 of	 RTM,	 the	more	 efficient	 the	 process.	Most	 of	 the	 technologies	 are	
placed	along	 the	diagonal	 of	 the	parameter	 space	 “d-P”,	 indicating	 that	 higher	delivery	 rates	 result	 in	
lower	 resolution,	 and	 fabricating	 fine	 details	 are	 in	 contrast	with	 fast	manufacturing.	 Here,	we	briefly	
outline	 the	most	common	technologies	 in	each	of	 these	strategies	 in	order	 to	 illustrate	and	 illuminate	
their	differences,	advantages,	and	limitations.			
Scaffold-based	 strategies.	 The	 most	 commonly	 used	 technologies	 in	 scaffold-based	 biofabrication	
comprise	i)	3D	printing,	ii)	Light-based	technologies	such	as	selective	laser	sintering	(SLS),	selective	laser	
ablation,	stereolithography	(SLA)	and	two-photon	polymerization	(2PP),	iii)	fused	deposition	modelling	
(FDM),	 iv)	 wet-spun	 automated	 extrusion	 systems,	 v)	 3D	 plotting,	 v)	 ink-jet	 printing,	 and	 vi)	
electrospinning	 (Figure	 2).	 Most	 of	 these	 technologies	 were	 originally	 developed	 as	 additive	
manufacturing	 technologies	 for	 rapid	 prototyping,	 but	 are	 included	 as	 biofabrication	 strategies	 when	
used	for	biomedical	applications.		
3D	printing.	With	3D	printing,	a	jet	of	binder	is	directed	at	a	powder-bed	to	define	a	pattern	controlled	
by	 computer-aided	design/computer-aided	manufacturing	 (CAD/CAM)	 software.	 The	 solvent	 binds	 the	
powder,	thus	forming	a	slice	of	solid	material;	subsequently	a	new	layer	of	powder	is	laid	down	and	the	
process	is	repeated	to	build	the	scaffold	layer-by-layer	[6,	7].	The	unbound	powder	acts	as	a	support	for	
the	 object	 during	 building,	 allowing	 the	 easy	 fabrication	 of	 re-entrant	 and	 hollow	 objects.	 It	 can	 be	
difficult	 to	 remove	 excess	 unbound	 grains	 and	 remnants	 of	 used	 solvents/binder.	 In	 this	 respect,	 it	 is	
important	to	highlight	that	the	term	3D	printing	should	only	refer	to	this	specific	additive	manufacturing	
technology.	This	technology	allows	the	fabrication	of	structures	with	a	lateral	resolution	controlled	by	a	
combination	of	the	powder	particle	size	and	the	volume	that	the	solvent	penetrates	by	capillary	action.	
Current	 commercial	 systems	 have	 a	 feature	 resolution	 around	 300	µm,	which	 is	 suboptimal	 if	 precise	
control	of	cell	positioning	is	required	after	scaffold	fabrication.	Its	RTM	ratio	is	about	0.1*10
-3
	m
2
/min,	so	
at	the	medium	level	of	manufacturing	efficiency.	
Light-based	technologies.	SLS	uses	a	 laser	where	the	beam	of	 light	 is	selectively	directed	to	a	powder-
bed,	generating	local	heat	and	forming	patterns	of	fused	material;	after	its	solidification,	a	new	layer	of	
powder	 is	 laid	 down	 and	 the	 process	 is	 repeated	 to	 build	 the	 scaffold	 layer-by-layer.	 A	 variety	 of	
thermoplastic	polymers	[8],	metals	(in	this	case	SLS	is	called	selective	laser	melting),	ceramics,	mixtures	
of	 polymer-ceramic	 [9]	 and	 polymer	 encapsulated	 ceramic	 [10]	 can	 be	 used,	 but	 the	 required	 high	
temperatures	limit	the	utility	of	SLS	for	biofabrication	processes.	The	source	materials	that	are	normally	
used	 require	 extra	 processing	 to	 obtain	 these	 in	 powder	 form	 with	 a	 precise	 and	 narrow	 size	
granulometry.	Selective	laser	ablation	works	in	the	opposite	way	by	ablating	of	a	solid	material	using	a	
very	 short	 time	 duration	 laser	 pulse	 [11,	 12].	 If	 the	 ablation	 process	 is	 conducted	 in	 all	 of	 the	 three	
directions	or	if	laminated	porous	films	are	stacked	and	bonded	on	top	of	each	other,	a	3D	structure	can	
be	created.	These	techniques	have	proved	useful	for	the	fabrication	of	improved	tissue	constructs	upon	
seeding	 the	 scaffold	 with	 cells	 [13-15].	 These	 technologies	 do	 not	 allow	 the	 direct	 incorporation	 of	
pharmaceuticals,	 biomacromolecules	 (proteins,	 growth	 factors)	 and	 cells	 into	 the	 scaffold.	 Thus,	 they	
could	 be	 considered	 biofabrication	 technologies	 only	 when	 the	 fabricated	 scaffolds	 are	 designed	
following	 hierarchical	 or	 smart	 principles	 to	 influence	 cell	 activity	 and	 achieve	 functional	 biological	
constructs,	as	previously	discussed	[1].	In	these	methods,	the	resolution	of	the	printed	pattern	depends	
on	 the	 laser	 spot	 size,	 the	 thermal	 conductivity,	 the	 surface	 tension	 and	 the	 absorption	 of	 the	 raw	
materials,	and	the	grain	size.	Due	to	heat	conduction,	resolution	 is	 inevitably	 larger	than	the	spot	size.	
The	 RTM	 is	 around	 1*10
-3
	m
2
/min	 for	 both	 technologies,	which	means	 that	 these	 techniques	 are	 fast	
even	if	the	resolution	is	comparable	with	that	of	other	methods.	
A	promising	modification	of	SLS	that	can	release	active	compounds	(e.g.	ribonuclease,	an	exceptionally	
stable	 enzyme),	 is	 surface	 selective	 laser	 sintering	 (SSLS)	 [16],	 which	 uses	 an	 infrared	 laser	 to	 sinter	
powder	 substrates.	 In	 this	 case,	 the	 radiation	 is	 not	 absorbed	by	 the	 polymer	 particles	 but	 by	 carbon	
micro-particles	spread	on	the	surface	of	the	polymer	particles.	However,	due	to	several	challenges,	such	
as	the	use	of	carbon	micro	particles	without	proven	track	record	of	biocompatibility,	 the	processing	of	
polymers	 into	 powder,	 the	 lack	 of	 extensive	 studies	with	 unstable	 biologically	 active	 compounds,	 this	
technology	is	not	yet	ready	for	the	clinic.		
SLA,	in	which	light	is	used	to	solidify	a	photosensible	resin,	has	been	typically	used	to	produce	a	negative	
replica	 that	 is	 filled	 with	 ceramic	 or	metallic	 slurries,	 and	 subsequently	 removed	 by	 sintering	 at	 high	
temperatures	[17].	Biocompatible	and	biodegradable	photosensitive	polymers	that	can	be	used	in	SLA	to	
directly	 fabricate	 3D	 scaffolds	 are	 also	 being	 developed	 and	 investigated.	 A	 few	 newly	 developed	
photosensitive	 resins	are	 starting	 to	appear	 in	 the	biomaterials	 field	 for	 this	purpose,	which	have	also	
opened	the	possibility	to	use	a	 light	projection	system	instead	of	a	 laser	source	(known	as	Digital	Light	
Processing,	DLP
TM
)	[18,	19].	Some	of	these	also	comprise	hydrogel	formulations,	which	would	then	allow	
the	incorporation	of	cells	into	the	biofabrication	process.	Despite	enhanced	resolution	(~20-40	µm)	with	
SLA,	the	biocompatibility	of	these	photopolymers	and	the	photoinitiators	used	for	their	cross-linking	has	
to	be	fully	validated.	Incorporation	of	any	biological	material,	including	cells,	depends	on	their	sensitivity	
to	the	light	source	used	[20].	In	addition,	this	method	is	limited	to	a	cell	type	that	could	be	incorporated	
into	a	hydrogel.	Using	the	data	in	literature,	an	RTM	ratio	of	about	0.5*10
-3
	m
2
/min	can	be	estimated	for	
SLA,	which	 places	 this	method	 among	 the	more	 efficient	 techniques.	 In	 case	 of	 DLP,	 the	 RTM	 can	 be	
increased	 to	 2*10
-3
	 m
2
/min	 thanks	 to	 parallelization	 of	 the	 light	 beam.	 An	 improvement	 of	 SLA	 with	
respect	 to	 spatial	 resolution	 is	 two-photon	 polymerization	 (2PP),	 where	 a	 spatially	 and	 temporally	
confined	 laser	beam	polymerizes	a	photosensitive	 resin	 [21,	22].	The	 resolution	of	 this	 technology	can	
reach	the	sub-micron	scale.	Although	new	photocurable	biomaterials	with	satisfactory	biocompatibility	
are	being	developed	and	 the	 speed	of	 this	 fabrication	process	has	 improved,	 further	progress	 in	both	
materials	development	and	fabrication	rate	is	needed.	The	RTM	is	0.05*10
-3
	m
2
/min,	which	means	that	
2PP	has	a	very	high	resolution	despite	taking	a	long	time	to	manufacture	big	structures.		
Fused	deposition	modeling.	FDM	has	been	extensively	used	to	fabricate	custom-made	scaffolds	and	to	
modulate	their	mechanical	properties	for	tissue	engineering	applications,	with	encouraging	results	[23-
25].	In	FDM,	molten	thermoplastic	polymers	are	extruded	into	filaments.	These	filaments	are	deposited	
to	form	a	layer	and	a	3D	scaffold	is	built	layer-by-layer.	The	entire	process	is	controlled	by	a	CAD	design.	
A	 number	 of	 biocompatible	 thermoplastics	 have	 been	 developed	 and	 processed	 with	 this	 technique.	
However,	 the	 majority	 of	 the	 published	 work	 has	 used	 polycaprolactone	 as	 the	 polymer	 of	 choice	
because	of	its	relatively	low	melting	temperature	and	its	commercial	availability	in	medical	grades.	Many	
other	extrusion-based	tools	inspired	by	FDM	have	been	developed	to	fabricate	3D	scaffolds.	These	also	
comprise	 multi-dispensing	 systems,	 such	 as	 3D-fiber	 deposition	 (3DF)	 and	 bioextrusion	 that	 allow	
depositing	 different	 materials	 at	 the	 same	 time	 to	 produce	 constructs	 with	 locally	 differing	 physico-
chemical	 properties	 [4,	 23,	 26].	 The	 main	 difference	 between	 FDM	 on	 one	 hand,	 and	 3DF	 and	
bioextrusion	on	the	other,	 is	that	 in	3DF	and	bioextrusion	the	biomaterials	are	 loaded	in	a	cartridge	as	
pellets	 or	 particles	 instead	 of	 being	 extruded	 in	 a	 filament	 form.	 This	 approach	 has	 the	 advantage	 of	
expanding	the	palette	of	biomaterials	that	can	be	used	compared	to	FDM.	An	associated	disadvantage	of	
3DF	and	bioextrusion	is	the	higher	susceptibility	to	thermal	degradation	due	to	the	long	residence	times	
of	 the	 raw	 material	 at	 high	 temperatures.	 Although	 FDM,	 3DF,	 and	 bioextrusion	 techniques	 have	
considerably	 improved	 the	 quality	 of	 tissue	 engineered	 constructs	 with	 respect	 to	 their	 functional	
performance	[25,	27-29],	the	high	temperatures	involved	during	the	fabrication	of	molten	polymers	may	
limit	the	direct	 incorporation	of	biological	factors	with	the	technique.	A	solution	could	be	envisioned	if	
not	 only	 metallic	 [30]	 or	 ceramic	 pastes	 [31]	 are	 employed,	 but	 also	 polymeric	 pastes	 that	 can	 be	
processed	 at	 room	 temperature.	 Alternatively,	 surface	 modification	 techniques	 could	 be	 used	 to	
functionalize	 the	 fibres	 and	 allow	 grafting	 of	 the	 bioactive	 agents	 in	 specific	 sites	 [32].	 Additionally,	
hydrogels	 that	 encapsulate	 biological	 components	 could	 be	 deposited	 together	 with	 thermoplastic	
materials,	thereby	circumventing	the	limitations	[33,	34]	imposed	by	the	high	temperatures.	FDM,	3DF,	
and	bioextrusion	have	 the	highest	RTM	 ratio	of	 all	methods,	 around	1*10
-3
	m
2
/min.	Because	 the	post	
processing	phase	is	practically	non-existent,	there	is	a	limited	need	for	intervening	layers	or	binders	and	
solvents	to	remove	excess	material,	as	with	most	other	techniques.	
Pressure-assisted	 microsyringe	 deposition	 (PAM)	 and	 other	wet-spun	 automated	 extrusion	 systems	
have	been	developed	to	solve	the	disadvantages	associated	with	high	temperatures	in	FDM,	at	the	same	
time	achieving	scaffolds	with	a	higher	fiber	resolution	(~80	µm	for	FDM	vs	10	µm	for	PAM)	[35,	36].	PAM	
is	 part	 of	 the	 PAM
2
	 system,	where	 several	working	modules	 can	 be	mounted	 in	 parallel	 on	 a	 robotic	
micro-positioner,	for	processing	at	the	same	time	synthetic	and	natural	polymer	solutions	and	living	cell	
suspensions	 [36,	37].	 The	main	drawback	of	wet-spun	extrusion	based	 technologies	 is	 the	 low	vertical	
dimension	 (when	 high	 resolution	 is	 aimed)	 resulting	 in	 a	medium	 RTM	 ratio	 of	 0.5*10
-3
	m
2
/min.	 This	
implies	 that	 thick	 constructs	 take	more	 time	 to	 be	 fabricated	 than	with	 other	 extrusion	 technologies.	
Recent	 progress	 by	 the	 Lewis	 group	 might,	 however,	 solve	 such	 limitations	 by	 fabricating	 arrays	 of	
nozzles	that	can	deposit	multiple	filaments	at	the	same	time	[38].		
The	 major	 limitation	 of	 most	 scaffold	 fabrication	 processes	 reported	 in	 the	 literature	 is	 that	 each	
technique	is	applicable	only	 in	particular	conditions	(e.g.	rheology,	pressure,	temperature,	voltage	etc.)	
that	 restrict	 the	 choice	 of	materials.	 Hydrogels	 composed	 of	 natural	 polymers	 (e.g.,	 collagen,	 gelatin,	
hyaluronic	acid),	either	 in	combination	with	additional	biological	 factors	or	used	alone,	are	 intrinsically	
biocompatible	 and	 biodegradable,	 and	 possess	 biological	 cues	 [39].	 However,	 these	 natural-polymer	
hydrogels	are	difficult	to	process	with	the	techniques	discussed	so	far.	As	an	alternative,	scaffolds	made	
of	natural	biomaterials	can	be	produced	by	indirect	fabrication	techniques	(e.g.	casting	a	biomaterial	into	
a	sacrificial	mould	realized	by	additive	manufacturing	processes).	 Indirect	methods	to	produce	additive	
manufactured	scaffolds	have	emerged	in	a	number	of	different	approaches	with	promising	results	[40].	
The	development	of	an	alkali	soluble	photopolymer	allowed	the	use	of	indirect	additive	manufacturing	
with	hydrogels	[41].	 In	particular,	gelatin	and	collagen	scaffolds	could	be	produced	by	applying	indirect	
SLS	manufactured	moulds	with	high	resolution	and	a	minimum	pore	or	strut	size,	on	the	scale	of	several	
tens	of	micrometers	 [42,	43].	 Indirect	methods	 could	be	also	 combined	with	 conventional	 techniques,	
such	as	salt	leaching	and	phase	inversion,	to	fabricate	dual-pore	scaffolds	[44,	45].	Some	drawbacks	still	
exist	with	 indirect	approaches,	 including	the	poor	resolution	of	the	additive	manufacturing	techniques,	
the	 casting	 procedure	 and	 the	 extraction	 methods.	 For	 these	 reasons	 the	 RTM	 ratio	 is	 ~0.03*10
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Bioplotting	and	 ink-jet	bioprinting.	Whereas	all	of	 the	above-mentioned	methods	have	demonstrated	
different	degrees	of	success	in	fabricating	3D	scaffolds	that	can	accommodate	cells	that	can	develop	into	
tissues	or	proto-tissue	structures,	most	of	them	are	incapable	of	simultaneously	depositing	biomaterials	
and	cells.	Therefore,	cells	need	to	be	separately	seeded	into	the	scaffolds	produced	by	these	techniques.	
This	 limits	the	flexibility	to	mimic	cell	distributions	 in	native	tissues	particularly	when	strategies	for	the	
regeneration	of	multiple	tissue	interfaces	or	organs	are	to	be	developed.	Three	main	set	of	technologies	
that	have	demonstrated	the	ability	to	incorporate	cells	during	the	process	of	additive	manufacturing	into	
a	 biomaterial	 carrier	 are	 3D	 plotting	 (or	 also	 known	 as	bioplotting	 and	 extrusion	 bioprinting),	 ink-jet	
bioprinting,	and	valve-jet	bioprinting.	In	bioplotting,	the	cells	are	typically	encapsulated	into	a	hydrogel	
carrier	biomaterial	 and	extruded	by	 the	application	of	pressure,	 similarly	 to	wet-spun	extrusion	based	
technologies	 [46-48].	 This	 technique	 allows	 the	deposition	of	 different	 cell	 types	 in	 different	 hydrogel	
formulations,	 but	 is	 still	 limited	 in	 terms	 of	 speed	 of	 production	 and	 fabrication	 of	 constructs	 with	
complex	shape,	mostly	due	to	the	lack	of	optimal	hydrogel	carriers	(also	called	bioinks).	The	technique	
also	carries	some	 limitations	 if	a	stable	structure	 is	 to	be	formed.	For	example,	 it	may	be	necessary	to	
use	 a	 plotting	 bath	 containing	 a	 fluid	 of	 matching	 density	 and	 viscosity	 to	 the	 extruded	 material	 to	
prevent	 sagging	or	deformation	of	 the	 construct	 immediately	after	extrusion,	or	alternatively	 to	use	a	
hydrogel	with	sufficient	viscosity	to	self-sustain	its	own	weight	after	processing.	An	additional	approach	
that	has	emerged	is	the	extrusion	of	material	into	3D	space	of	another	material,	in	contrast	to	building	a	
structure	 from	 a	 surface	 [49-51].	 This	 has	 been	 most	 commonly	 performed	 with	 hydrogels	 (e.g.,	
continuous	or	colloidal	suspensions)	where	the	material	displaces	as	another	material	is	extruded	into	it,	
and	 has	 been	 used	 to	 print	 suspended	 objects	 or	 open-channel	 structures	 with	 the	 use	 of	 sacrificial	
materials.	
In	ink-jet	bioprinting,	cells	encapsulated	into	hydrogel	carriers	are	dispensed	in	a	droplet	fashion.	By	ink-
jet	 bioprinting,	 it	 is	 possible	 to	 exquisitely	 control	 the	 number	 of	 cells	 per	 deposited	 droplet,	 thus	
resulting	 in	a	finer	control	 in	cell	distribution	in	the	fabricated	constructs	[52,	53].	The	development	of	
optimal	hydrogels	as	bioinks	for	both	bioplotting	and	ink-jet	bioprinting	remains	a	challenge	and	the	fluid	
requirements	 for	both	methods	are	quite	different	 in	 terms	of	 fluid	viscosity	and	surface	 tension	 [54].	
The	 RTM	 ratio	 is	 around	 0.5*10
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/min	 for	 bioplotting	 due	 to	 rapid	 scaffold	 production	 but	 low	
resolution,	 and	 around	 0.1*10
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/min	 for	 ink-jet	 bioprinting	 due	 to	 high	 resolution	 but	 also	 high	
fabrication	time	per	unit	volume.	In	both	technologies	the	presence	of	living	cells	in	the	bioink	limit	the	
RTM	 ratio:	 higher	 extrusion	 flow	 and	 smaller	 nozzles	 can	 induce	 damages	 due	 to	 shear	 stress	 on	 cell	
membranes	[46-53].		
Similar	to	the	ink-jet	technique,	valve-jet	bioprinting	is	a	non-contact,	droplet-based	method	where	cells	
are	 printed	with	 or	 without	 hydrogel	 carriers	 [55].	 The	 actuation	mechanism	 of	 valve-jet	 is	 based	 on	
pneumatic	pressure	and	ejection	of	droplets	 is	 controlled	by	 solenoid	microvalves	 instead	of	piezo-	or	
thermal	 actuators	 as	 in	 ink-jet	 printing	 [56].	 Currently,	 the	 printing	 resolution	 (e.g.	 nano-liter	 droplet)	
and	throughput	(e.g.	1-1000	Hz)	of	valve-jet	bioprinting	 lie	between	bioplotting	and	ink-jet	bioprinting,	
so	does	the	printable	fluid	viscosity	range	(up	to	100	Pa.s).	As	the	technology	is	not	limited	by	the	nozzle	
size	(like	ink-jet	printing),	the	shear	stress	can	be	minimized	and	therefore	the	technology	is	amenable	to	
print	delicate	human	pluripotent	stem	cells	[57].	The	RTM	ratio	is	therefore	around	0.3*10
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the	valve-jet	bioprinting.		
Electrospinning.	A	further	promising	technique	for	scaffold	fabrication	is	electrospinning.	This	technique	
produces	fiber	meshes	with	physical	features	mimicking	those	of	the	native	extracellular	matrix	(ECM).	
The	fiber	meshes	are	created	by	passing	a	biomaterial	solution	through	a	high	voltage	electric	field	near	
the	deposition	nozzle.	At	a	defined	voltage	threshold,	which	is	specific	for	a	defined	biomaterial	solution,	
the	surface	tension	of	the	biomaterial	solution	is	overcome	by	the	applied	electric	field,	resulting	in	the	
formation	 of	 an	 electrohydrodynamic	 Taylor	 cone	 from	 which	 fibers	 are	 spun	 and	 collected	 on	 a	
grounded	 target	 plate	 [58].	 Despite	 being	 a	 relatively	 old	 technology,	 originally	 developed	 for	 textile	
fibre	production,	this	technique	is	now	widely	used	by	the	tissue	engineering	and	regenerative	medicine	
community	because	of	the	wide	range	of	materials	available	to	the	technique	and	the	methods	of	fibre	
collection	 that	allow	 for	an	expansive	 spectrum	of	 structures	and	 shapes	 to	be	 fabricated	 [59,	60].	An	
important	recent	development	in	the	field	of	electrospinning	is	the	possibility	to	control	the	deposition	
of	 fibers	at	a	 scale	of	a	 single	 fiber.	This	has	been	achieved	by	 the	so-called	near	 field	electrospinning	
technique	for	biomaterials	in	solution	and	by	melt	electrospinning	writing	for	molten	polymers	[61,	62].	
Together	 they	 constitute	 the	method	 of	 electrohydrodynamic	writing	 in	which	 predictable	 fiber	 paths	
are	 used	 to	 direct-write	 small	 diameter	 fibers	 onto	 a	 translating	 collector.	 This	 new	 electrospinning	
modality	can	potentially	be	used	to	create	scaffold	structures	that	can	better	mimic	the	native	ECM	not	
only	from	the	physical	dimensions	of	the	constituent	fibres,	but	also	in	terms	of	structural	organization.	
Although	 cells	 have	 been	 shown	 to	maintain	 their	 viability	 after	 the	 electrospinning	 process	 [63,	 64],	
reports	 describing	 the	 possibility	 of	 electrospinning	 cell-laden	 hydrogels	 are	 still	 limited	 [65,	 66].	 The	
RTM	ratio	of	this	technique	is	currently	around	0.1*10
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Scaffold	 free	 strategies.	 Along	 with	 the	 scaffold-based	 approaches,	 a	 number	 of	 alternative	
biofabrication	strategies	that	use	biomaterials	to	provide	only	structural	 integrity	have	been	developed	
(Figure	3).	The	first	examples	of	these	strategies	are	the	works	of	Forgacs	and	co-workers	who	dispensed	
cell	spheroids	and	cylinders	into	a	hydrogel	bed	using	special	purpose	extrusion	bioprinters	[67-69].	The	
hydrogel	is	used	as	a	support,	while	a	tissue-like	structure	forms	by	exploiting	the	biophysical	principles	
of	tissue	liquidity	that	governs	the	fusion	of	adjacent	cell	aggregates.	In	this	manner,	branched	vascular	
networks	[67,	70],	nerve	grafts	[68,	71]	and	other	tissue	modules	[69]	have	been	successfully	fabricated.	
Additional	applications	of	this	technology	resulted	in	commercial	products	in	the	form	of	architecturally	
and	functionally	correct	human	tissue	constructs	for	drug	toxicology	essays	[72].!The	principal	limitations	
of	this	approach	are	i)	the	relatively	slow	fusion	of	the	cell	aggregates,	which	takes	typically	at	least	24-
48	hours	depending	on	 the	 cells	 used	and	may	 lead	 to	 a	 somewhat	 inhomogeneous	 construct,	 ii)	 low	
spatial	resolution,	due	to	the	use	of	micropipettes	of	relatively	 large	diameter	(300	or	500	μm)	for	the	
preparation	 and	 deposition	 of	 gels	 and	 cells;	 and	 iii)	 a	 still	 limited	 diffusion	 of	 nutrients	 when	 large	
constructs	are	fabricated.	Due	to	these	limitations	and	to	the	low	resolution	of	this	method,	its	RTM	ratio	
is	less	than	0.001*10
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A	 similar	 technology	was	 developed	 by	Nakayama	 and	 co-workers,	who	 used	 an	 ingenious	 skewering	
system	 [73,	 74],	 wherein	 the	 cell	 spheroids	 are	 placed	 on	 fine	 metallic	 needles	 (i.e.	 skewers),	
geometrically	positioned	as	to	be	consistent	with	the	shape	of	the	desired	organ	structure	(e.g.	tubular	
construct;	 Figure	 4).	 The	 novelty	 in	 this	 technology	 is	 that	 the	 needles	 prevent	 the	 otherwise	
unavoidable	 shrinking	 of	 the	 construct	 upon	 the	 fusion	 of	 the	 spheroids	 (at	 least	 in	 one	 direction).		
Others	used	a	tangram-based	concept,	where	different	cellular	shapes	were	left	to	fuse	with	each	other	
and	 self-assemble	 into	 a	 macroscopic	 tissue	 construct	 [75-77].	 Achieving	 fully	 vascularized	 large	
constructs	with	these	tissue	liquidity-based	strategies	is	still	an	open	challenge.	Due	to	long	aggregation	
time	of	the	cell	aggregates,	the	RTM	ratio	is	slow,	less	than	0.001*10
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Another	 approach	 developed	 originally	 by	 Chrisey	 and	 colleagues	 [78]	 and	 later	 further	 adopted	 by	
Guillemot	and	colleagues	[79]	is	based	on	laser	assisted	bioprinting	(LAB).	This	technique	has	also	been	
known	as	 laser	 induced	 forward	 transfer	 (LIFT)	and	matrix	assisted	pulsed	 laser	evaporation	 (MAPLE).	
The	 deposition	 system	 is	 composed	 of	 three	 components:	 1)	 a	 pulsed	 laser	 source,	 2)	 a	 target	 from	
which	a	biological	material	is	printed,	and	3)	a	receiving	substrate	that	collects	the	printed	material.	The	
target	 is	 made	 of	 a	 thin	 absorbing	 layer	 of	 metal	 (such	 as	 gold	 or	 titanium)	 coated	 onto	 a	 laser	
transparent	support	(e.g.	glass	or	a	transparent	polymer	film).	Organic	materials	(molecules	or	cells)	are	
prepared	in	a	liquid	solution	(e.g.	culture	media	or	a	hydrogel	precursor),	and	deposited	at	the	surface	of	
the	 metal	 film.	 The	 laser	 pulse	 induces	 vaporization	 of	 the	 metal	 absorbing	 layer,	 resulting	 in	 the	
production	of	a	 jet	of	 liquid	solution	which	 is	deposited	onto	the	substrate	 [80].	The	resolution	of	 this	
system	 depends	 on	 parameters	 such	 as	 the	 thickness	 of	 the	 bioink	 layer	 coated	 onto	 the	 target,	 the	
surface	tension	and	the	viscosity	of	the	bioink,	the	wettability	of	the	substrate,	the	laser	fluence,	and	the	
air	gap	between	the	target	and	the	substrate.	LAB	has	a	fairly	low	RTM	ratio	around	0.04*10
-3
	m
2
/min,	
due	to	a	high	resolution	and	a	long	fabrication	time,	which	implies	that	thick	constructs	need	more	time	
for	 manufacture	 when	 compared	 with	 other	 techniques	 described	 before,	 and	 sometimes	 the	
production	time	of	large	size	structures	is	not	compatible	with	cell	processing	times.	
A	 different	 approach	 for	 the	 biofabrication	 of	 tissues	 and	 organs	 consists	 of	 bottom-up	 approaches	
(Figure	 3d-e-f),	 where	 micro	 and	 nano	 modules	 are	 first	 engineered	 and	 used	 as	 building	 blocks	 to	
fabricate	the	targeted	tissues.	One	of	the	most	successful	bottom-up	approaches	is	represented	by	the	
cell-sheet	engineering	method	developed	by	Okano	and	colleagues,	where	cells	are	cultured	till	reaching	
confluency	 on	 thermo-responsive	 culture	 plates,	 which	 can	 easily	 release	 the	 formed	 cell	 layers	 by	
switching	 the	 temperature	 from	 37	 °C	 to	 room	 temperature	 [81].	 Larger	 constructs	 comprised	 of	
multiple	 layers	 placed	 together	 in	 a	 conventional	 layer-by-layer	 method	 have	 been	 fabricated	 and	
successfully	brought	to	the	clinic	[82].	With	a	similar	approach,	L’Hereux	and	coworkers	developed	and	
brought	to	the	clinic	a	layer-by-layer	approach	to	fabricate	vascular	biological	grafts	from	cell	sheets	[83].	
Another	 classic	example	 is	 the	micro-masonry	concept	pioneered	by	 the	Khademhosseini	and	Demirci	
labs,	among	others,	where	micro-units	of	cell	 laden	hydrogels	are	used	as	regenerative	building	blocks	
[84-86].	The	modularity	of	this	approach	is	limitless.	Hydrogels	of	different	compositions	and	embedding	
different	 cells	 can	 be	 mixed.	 Recently,	 functionalization	 with	 DNA	 segments	 was	 also	 demonstrated,	
which	 resulted	 in	 a	 more	 biologically	 dynamic	 recognition	 of	 different	 building	 blocks	 during	 in	 vitro	
assembly	[87].	Furthermore,	such	blocks	can	be	also	precisely	positioned	using	micro-robots	[88].		
Despite	 the	 great	 flexibility	 promised	 by	 these	 methods,	 further	 studies	 are	 needed	 to	 effectively	
demonstrate	 the	 fabrication	 of	 clinically	 relevant	 large	 vascularized	 constructs	 to	 compensate	 for	 the	
known	 nutrient	 diffusion	 limitations	 of	 most	 hydrogel	 systems.	 Similar	 approaches	 have	 been	 also	
developed	 by	 combining	 solid	 micro-	 and	 nano-particles	 with	 cells,	 thus	 offering	 the	 advantage	 of	
engineering	 the	 shape	 and	 size	 of	 such	 objects,	 which	 can	 possibly	 offer	 further	 stimuli	 to	 direct	 cell	
differentiation,	particularly	when	stem	cells	are	used	[89,	90].	Their	use	in	combination	with	cells	offers	
the	possibility	 to	 impinge	on	 cellular	 condensation,	which	 results	 in	 tissue	 shrinking,	 thus	offering	 the	
opportunity	 to	maintain	 the	 dimensionality	 of	 large	 tissue	 constructs.	 For	 bottom-up	 approaches	 the	
RTM	 ratio	 is	 lower	 than	 0.001*10
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/min;	 these	 low	 values	 are	 due	 principally	 to	 a	 long	 time	 of	
fabrication	due	to	cell	sheets	or	microunits	production	and	time	necessary	for	the	fusion	of	the	different	
cell	sheets	or	microunits.	
Microfluidic	technology	has	also	boomed	in	the	recent	years	to	create	tissue-on-chip	platforms	that	can	
recapitulate	 key	 functions	 of	 targeted	 tissues	 and	 organs.	 These	 platforms	 are	 typically	 used	 in	
association	with	a	biomaterial	 formulation,	namely	hydrogel	networks,	 to	culture	cells	 in	3D	and	study	
mechanisms	behind	pathological	events	and	possible	treatments.	Examples	comprise	studies	on	cancer	
metastasis,	 lung,	 liver,	 intestine,	 and	 vessels,	 among	 others	 [91-95].	 Further	 development	 of	 these	
platforms	will	 comprise	 the	 integration	of	 sensors	 to	monitor	 in	 real-time	 cell	 and	 tissue	 functionality	
and	other	biomaterial	formulations	to	better	replicate	native	ECM	of	the	targeted	tissues	to	be	studied.	
A	 further	 advancement	 in	 these	 bio-assembly	 biofabrication	 strategies	 has	 been	 reported	 by	 the	
Takeuchi	group,	where	meter	long	cellular	fibers	have	been	created	through	microfluidic	technology	and	
proved	to	be	efficacious	in	the	regeneration	of	several	tissues	in	preclinical	animal	models	[96].	Cellular	
fibers	are	created	by	encapsulating	cell-containing	ECM	proteins	in	a	pre-gel	state	in	mechanically	stable	
Ca-alginate	 hydrogel	 carrier	 in	 a	 co-axial	 manner,	 and	 upon	 the	 gelation	 of	 the	 cell	 containing	 ECM	
dissolving	the	carrier	hydrogel.	These	fibers	have	also	been	weaved,	thus	creating	cellular	fiber	scaffolds	
[97].	
	
Implications	for	an	integral	terminology	and	future	perspectives	
Since	the	pioneering	studies	that	kicked	off	the	research	activities	in	biofabrication	[98-101],	the	field	has	
seen	tremendous	progress,	which	includes	not	only	the	bioprinting	of	cells,	but	also	a	number	of	other	
approaches	where	cells	and	biomaterials	have	been	processed	to	fabricate	constructs	for	applications	in	
tissue	 engineering	 and	 regenerative	 medicine,	 and	 to	 fabricate	 in	 vitro	 models	 for	 pharmaceutical	
screening	[102,	103].	 In	addition,	biofabrication	can	also	serve	as	 inspiration	for	a	number	of	other	 life	
science	sectors,	including	food,	cosmetic,	sensing	and	diagnostic	industries	[104-106],	by	providing	new	
generic	biological	building	blocks.	Biofabrication	can	furthermore	be	used	to	describe	the	manufacture	of	
synthetic	 biological	 components	 including	 living	 cells	 that	 can	 be	 used	 for	 actuation	 and	 sensing	
applications	[107,	108];	such	structures	may	have	applications	as	 in	vivo	devices	that	do	not	require	on	
board	energy	storage.		
In	 this	 review,	 we	 have	 made	 a	 first	 attempt	 to	 define	 a	 metric	 that	 can	 compare	 the	 fabrication	
efficiency	 of	 the	main	 current	 biofabrication	 technologies	 and	 usable	 with	 new	methods	 as	 they	 are	
being	developed.	If	used	in	the	common	range	of	biofabrication	applications	(i.e.	minimum	feature	size	d	
less	than	500	μm),	although	dimensionally	complex,	the	RTM	ratio	will	objectively	classify	the	continuous	
optimization	 and	 advancement	 of	 current	 biofabrication	 technologies	 (see	 text	 box	 on	 Factors	
influencing	the	RTM	ratio).	A	practical	example	 is	 the	recent	development	of	a	new	SLA	technology	by	
the	 DeSimone	 group,	 called	 continuous	 liquid	 interface	 production	 (CLIP),	 which	 allows	 creating	 3D	
objects	 100	 times	 faster	 than	 conventional	 SLA	 [109].	Whether	 this	 technology	 could	be	 translated	 to	
biomaterials	 or	 cell-laden	hydrogels	 remains	 to	be	demonstrated	but	 an	estimate	of	 its	 RTM	 is	 5*10
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/min.	 Besides	 the	 limitation	 given	 by	 the	 physical	 principles	 behind	 each	 technology	 and	 by	 the	
chemistry	 of	 currently	 available	 biomaterials,	 the	 RTM	 ratio	 can	 be	 increased	 by	 parallelization	 of	
printing	 heads:	 light-based	 technologies	 better	 than	 others	 can	 exploit	 this	 route,	 and	 projection	 SLA	
(known	as	Digital	Light	Processing,	DLP
TM
)	is	a	clear	and	extreme	example	in	this	direction	[19].	Another	
technological	challenge	 is	 the	 fabrication	of	complex	anatomically	 shaped	constructs.	Whereas	current	
bioprinting	 technologies	 can	 already	 achieve	 non-intricate	 structures,	 the	 recent	 development	 of	 new	
colloidal	 inks	and	optimized	bathing	 stages	where	 the	bioprinting	process	 takes	place	 could	offer	new	
solutions	to	further	increase	the	degree	of	complexity	in	mimicking	native	organs	[50,	51].	In	particular,	
the	use	of	high	buoyant	density	liquids	[110],	sacrificial	fugitive	materials	[111]	or	granular	gels	[50,	112]	
as	media	into	which	depositing	bioinks	is	becoming	a	new	exciting	avenue	to	fabricate	larger	and	more	
complex	constructs.	For	a	more	 in-depth	review	on	supporting	temporary	sacrificial	materials	we	refer	
elsewhere	[113].			
With	the	development	of	new	bioprinting	processes,	it	is	nowadays	possible	to	manufacture	tissues	with	
different	levels	of	complexity	(Figure	5	a-c).	This	is	achieved	by	heterogeneous	combination	of	different	
cells	 and	 bioinks.	 The	 degree	 of	 complexity	 needed	 to	 mimic	 and	 eventually	 replace	 a	 tissue	 and	
ultimately	 an	 organ	 has	 started	 to	 be	 considered	 for	 constructs	 tested	 in	 vitro	 [114,	 115]	 and	 in	 vivo	
[116].	 With	 initial	 minor	 functional	 outcomes,	 a	 further	 understanding	 on	 the	 level	 of	 mimicry	 and	
complexity	necessary	to	achieve	optimal	functional	tissue	or	organ	replacement	is	expected	as	the	field	
matures.						
In	 the	 perspective	 of	 commercial	 scale	 production,	 other	 standards	 of	 quality	 should	 be	 taken	 into	
consideration,	 such	 as:	 (i)	 accuracy,	 or	 how	 closely	 a	manufacturing	machine’s	 output	 conforms	 to	 a	
tolerance	within	 a	 specified	 dimensional	 range,	 and	 (ii)	 repeatability,	which	 captures	 the	 equipment’s	
capability	 to	 produce	 consistent	 output,	 time	 after	 time.	 These	 parameters	 are	 needed	 to	 reduce	 the	
extrinsic	variability	of	the	advanced	tissue	models,	due	to	micro-environmental	properties,	 limiting	the	
intrinsic	 variability	 related	 to	 the	 cells	 themselves	 [40].	 Quality	 control	 requires	 a	 consensus	 on	
metrology:	 limiting	 the	 discussion	 to	 geometrical	 consideration,	 a	 least	 squares	 fit	 of	 a	 point	 cloud	
representing	the	scaffold	(e.g.	from	a	µCT	scan)	to	its	CAD	model	can	give	a	measure	of	the	fabrication	
error	 [117,	118].	 Interestingly,	 additive	manufacturing	processes	allow	 for	 in-process	 inspection	of	 the	
internal	structure	of	a	part.	Furthermore,	the	accuracy	over	time	(long	term	stability)	is	directly	related	
to	the	off-the-shelf	availability	and,	in	a	more	prosaic	way,	to	shipping	and	storing	methods	[119].		
Finally,	new	hydrogels	need	to	be	developed	that	are	able	to	maintain	at	the	same	time	cell	viability	and	
activity,	and	the	physical	shape	of	the	final	printed	construct	[120-122].	The	dynamic	behavior	of	native	
ECM	 is	 an	 appealing	 feature	 that	 could	 be	 incorporated	 into	 new	 bioinks	 in	 future	 biofabrication	
strategies.	 In	 this	 respect,	what	 is	nowadays	called	4D	printing	could	allow	such	 integration	where	the	
use	 of	 stimuli	 responsive	 materials	 allows	 for	 a	 spatio-temporal	 change	 of	 a	 3D	 object	 [123,	 124].	
Whether	 we	 are	 really	 witnessing	 4D	 printing,	 a	 process	 that	 should	 be	 defined	 as	 a	 programmed	
temporal	shape	change	occurring	during	the	3D	manufacturing	itself,	or	not	is	still	to	be	clarified	in	the	
field.	We	advocate	for	cautious	use	of	the	term	4D	printing,	as	all	reports	so	far	published	in	 literature	
show	3D	objects	 that	can	change	shape	after	 the	3D	manufacturing	process.	Nonetheless,	 these	 time-
morphing	3D	objects	are	certainly	an	exciting	new	development	of	conventional	additive	manufacturing,	
which	would	be	thrilling	to	see	to	be	translated	into	novel	biofabrication	strategies	(see	also	outstanding	
questions).		
	
Concluding	remarks	and	recommended	guidelines	
As	the	biofabrication	community	expands	and	the	applications	of	this	technology	grow,	it	is	important	to	
establish	 a	 set	 of	 definitions	 and	 terminology	 that	 will	 help	 normalize	 discussion	 and	 reports	 of	
developments	 in	 the	 field.	 Some	 attempts	 have	 been	 already	 made	 in	 the	 case	 of	 3D	 scaffolds,	 for	
example,	 with	 the	 National	 Institute	 for	 Standards	 and	 Technology	 of	 the	 United	 States	 of	 America	
adopting	3D	scaffolds	fabricated	by	additive	manufacturing	technologies	as	standards	for	3D	cell	culture	
[125].	Further	standards	could	be	sought	into	the	realm	of	advanced	manufacturing,	as	recently	pointed	
out	 by	 Hutmacher	 and	 co-workers,	 who	 coined	 the	 term	 “additive	 biomanufacturing”	when	 standard	
norms	like	ASTM	or	ISO	are	applied	to	the	biofabrication	field	[126].	In	this	context	it	is	important	to	note	
that	biomanufacturing	means	the	use	of	living	organisms	to	manufacture	a	product.	In	a	recent	review,	
the	 term	has	been	defined	more	precisely	 as	 "a	 type	of	manufacturing	 that	utilizes	biological	 systems	
(e.g.,	 living	 microorganisms,	 resting	 cells,	 plants,	 animals,	 tissues,	 enzymes,	 or	 in	 vitro	 synthetic	
(enzymatic)	 systems)	 to	 produce	 commercially	 important	 value-added	 biomolecules	 for	 use	 in	 the	
agricultural,	 food,	energy,	material,	and	pharmaceutical	 industries"	 [127].	Therefore,	we	wish	 to	stress	
that,	according	to	the	most	recent	definition	of	biofabrication	[1],	“additive	biomanufacturing”	is	a	sub-
field	of	biofabrication.		
Here,	we	propose	a	clarification	and	classification	of	the	different	biofabrication	terminologies	in	current	
use.	In	this	respect,	we	recommend	that	the	term	3D	printing	no	longer	be	used	as	a	general	term	for	all	
additive	manufacturing	technologies	applied	to	biofabrication	strategies,	as	3D	printing	represents	 just	
one	 such	 technology	 as	 previously	 described.	 Rather,	we	 recommend	 using	 the	 name	 of	 that	 specific	
technology	used	to	create	a	biofabricated	construct,	as	outlined	in	this	article.	When	referring	to	more	
general	biofabrication	strategies	in	tissue	engineering	and	regenerative	medicine,	we	recommend	using	
the	two	general	terms	bioprinting	or	bioassembly.	As	we	previously	defined	[1],	bioprinting	refers	to	the	
use	of	computer-aided	transfer	processes	for	patterning	and	assembling	 living	and	non-living	materials	
with	 a	 prescribed	 2D	 or	 3D	 organization	 in	 order	 to	 produce	bio-engineered	 structures;	 bioassembly	
refers	 to	 the	 fabrication	 of	 hierarchical	 constructs	 with	 a	 prescribed	 2D	 or	 3D	 organization	 through	
automated	 assembly	 of	 pre-formed	 cell-containing	 fabrication	 units	 generated	 via	 cell-driven	 self-
organization	or	 through	preparation	of	hybrid	cell-material	building	blocks.	We	advise	the	members	of	
the	community	to	adopt	this	terminology	approach	in	their	new	studies	and	that	the	media	will	report	
advances	in	the	field	with	the	correct	language,	instead	of	broadly	using	only	the	term	3D	printing.		
	
References	
[1]	 J.	 Groll,	 T.	 Boland,	 T.	 Blunk,	 J.A.	 Burdick,	 D.W.	 Cho,	 P.D.	 Dalton,	 B.	 Derby,	 G.	 Forgacs,	 Q.	 Li,	 V.A.	
Mironov,	L.	Moroni,	M.	Nakamura,	W.	Shu,	S.	Takeuchi,	G.	Vozzi,	T.B.	Woodfield,	T.	Xu,	J.J.	Yoo,	J.	Malda,	
Biofabrication:	reappraising	the	definition	of	an	evolving	field,	Biofabrication	8(1)	(2016)	013001.	
[2]	W.	Gao,	Y.B.	Zhang,	D.	Ramanujan,	K.	Ramani,	Y.	Chen,	C.B.	Williams,	C.C.L.	Wang,	Y.C.	Shin,	S.	Zhang,	
P.D.	 Zavattieri,	 The	 status,	 challenges,	 and	 future	 of	 additive	 manufacturing	 in	 engineering,	 Comput	
Aided	Design	69	(2015)	65-89.	
[3]	 F.P.W.	 Melchels,	 M.A.N.	 Domingos,	 T.J.	 Klein,	 J.	 Malda,	 P.J.	 Bartolo,	 D.W.	 Hutmacher,	 Additive	
manufacturing	of	tissues	and	organs,	Progress	in	Polymer	Science	37(8)	(2012)	1079-1104.	
[4]	C.	Mota,	D.	Puppi,	F.	Chiellini,	E.	Chiellini,	Additive	manufacturing	 techniques	 for	 the	production	of	
tissue	engineering	constructs,	J	Tissue	Eng	Regen	Med	9(3)	(2015)	174-90.	
[5]	 C.B.	 Williams,	 F.	 Mistree,	 D.W.	 Rosen,	 A	 Functional	 Classification	 Framework	 for	 the	 Conceptual	
Design	of	Additive	Manufacturing	Technologies,	J	Mech	Design	133(12)	(2011).	
[6]	 R.A.	Giordano,	 B.M.	Wu,	 S.W.	Borland,	 L.G.	 Cima,	 E.M.	 Sachs,	M.J.	 Cima,	Mechanical	 properties	 of	
dense	polylactic	acid	 structures	 fabricated	by	 three	dimensional	printing,	 J	Biomater	Sci	Polym	Ed	8(1)	
(1996)	63-75.	
[7]	 A.	 Pfister,	 R.	 Landers,	 A.	 Laib,	 U.	 Hubner,	 R.	 Schmelzeisen,	 R.	 Mullhaupt,	 Biofunctional	 Rapid	
Prototyping	 for	 Tissue-Engineering	Applications:	 3D	 Bioplotting	 versus	 3D	 Printing,	 J	 Polym	 Sci	 Part	 A:	
Polym	Chem	42	(2004)	624-638.	
[8]	K.H.	Tan,	C.K.	Chua,	K.F.	Leong,	C.M.	Cheah,	W.S.	Gui,	W.S.	Tan,	F.E.	Wiria,	Selective	laser	sintering	of	
biocompatible	polymers	for	applications	in	tissue	engineering,	Biomed	Mater	Eng	15(1-2)	(2005)	113-24.	
[9]	R.L.	Simpson,	F.E.	Wiria,	A.A.	Amis,	C.K.	Chua,	K.F.	Leong,	U.N.	Hansen,	M.	Chandrasekaran,	M.W.	Lee,	
Development	 of	 a	 95/5	 poly(L-lactide-co-glycolide)/hydroxylapatite	 and	 beta-tricalcium	 phosphate	
scaffold	 as	 bone	 replacement	 material	 via	 selective	 laser	 sintering,	 Journal	 of	 biomedical	 materials	
research.	Part	B,	Applied	biomaterials	84(1)	(2008)	17-25.	
[10]	 W.Y.	 Zhou,	 S.H.	 Lee,	 M.	 Wang,	 W.L.	 Cheung,	 W.Y.	 Ip,	 Selective	 laser	 sintering	 of	 porous	 tissue	
engineering	 scaffolds	 from	 poly(L:	 -lactide)/carbonated	 hydroxyapatite	 nanocomposite	 microspheres,	
Journal	of	materials	science.	Materials	in	medicine	19(7)	(2008)	2535-40.	
[11]	 M.	 Takesada,	 E.	 Vanagas,	 D.	 Tuzhilin,	 I.	 Kudryashov,	 S.	 Suruga,	 H.	 Murakami,	 N.	 Sarukura,	 K.	
Matsuda,	 S.	Mononobe,	 T.	 Saiki,	M.	 Yoshimoto,	 S.	 Koshihara,	Micro-Character	 Printing	 on	 a	 Diamond	
Plate	by	Femtosecond	Infrared	Optical	Pulses	Jpn	J	Appl	Phys	42	(2003)	4613-4616.	
[12]	D.M.	C.,	L.	Grassi,	F.	Vozzi,	A.	Ahluwalia,	G.	Vozzi,	Development	of	a	novel	micro-ablation	system	to	
realise	 micrometric	 and	 well-defined	 hydrogel	 structures	 for	 tissue	 engineering	 applications,	 Rapid	
Prototyping	Journal	20(6)	(2014)	490-498.	
[13]	 J.K.	 Sherwood,	 S.L.	 Riley,	 R.	 Palazzolo,	 S.C.	 Brown,	 D.C.	Monkhouse,	M.	 Coates,	 L.G.	 Griffith,	 L.K.	
Landeen,	A.	Ratcliffe,	A	three-dimensional	osteochondral	composite	scaffold	for	articular	cartilage	repair,	
Biomaterials	23(24)	(2002)	4739-51.	
[14]	J.M.	Williams,	A.	Adewunmi,	R.M.	Schek,	C.L.	Flanagan,	P.H.	Krebsbach,	S.E.	Feinberg,	S.J.	Hollister,	
S.	Das,	Bone	tissue	engineering	using	polycaprolactone	scaffolds	fabricated	via	selective	laser	sintering,	
Biomaterials	26(23)	(2005)	4817-27.	
[15]	 O.	 Sarig-Nadir,	 N.	 Livnat,	 R.	 Zajdman,	 S.	 Shoham,	 D.	 Seliktar,	 Laser	 photoablation	 of	 guidance	
microchannels	into	hydrogels	directs	cell	growth	in	three	dimensions,	Biophys	J	96(11)	(2009)	4743-52.	
[16]	E.N.	Antonov,	V.N.	Bagratashvili,	M.J.	Whitaker,	 J.J.A.	Barry,	K.M.	Shakesheff,	A.N.	Konovalov,	V.K.	
Popov,	 S.M.	 Howdle,	 Three-Dimensional	 Bioactive	 and	 Biodegradable	 Scaffolds	 Fabricated	 by	 Surface-
Selective	Laser	Sintering,	Adv	Mater	17	(2005)	327-330.	
[17]	T.M.	Chu,	D.G.	Orton,	S.J.	Hollister,	S.E.	Feinberg,	J.W.	Halloran,	Mechanical	and	in	vivo	performance	
of	hydroxyapatite	implants	with	controlled	architectures,	Biomaterials	23(5)	(2002)	1283-93.	
[18]	 F.P.	 Melchels,	 J.	 Feijen,	 D.W.	 Grijpma,	 A	 poly(D,L-lactide)	 resin	 for	 the	 preparation	 of	 tissue	
engineering	scaffolds	by	stereolithography,	Biomaterials	30(23-24)	(2009)	3801-9.	
[19]	 R.	 Gauvin,	 Y.C.	 Chen,	 J.W.	 Lee,	 P.	 Soman,	 P.	 Zorlutuna,	 J.W.	 Nichol,	 H.	 Bae,	 S.	 Chen,	 A.	
Khademhosseini,	Microfabrication	 of	 complex	 porous	 tissue	 engineering	 scaffolds	 using	 3D	 projection	
stereolithography,	Biomaterials	33(15)	(2012)	3824-34.	
[20]	 Z.	 Wang,	 R.	 Abdulla,	 B.	 Parker,	 R.	 Samanipour,	 S.	 Ghosh,	 K.	 Kim,	 A	 simple	 and	 high-resolution	
stereolithography-based	 3D	 bioprinting	 system	 using	 visible	 light	 crosslinkable	 bioinks,	 Biofabrication	
7(4)	(2015)	045009.	
[21]	 A.	 Ovsianikov,	 B.N.	 Chichkov,	 Three-dimensional	 microfabrication	 by	 two-photon	 polymerization	
technique,	Methods	Mol	Biol	868	(2012)	311-25.	
[22]	 A.	 Ovsianikov,	 S.	 Schlie,	 A.	 Ngezahayo,	 A.	 Haverich,	 B.N.	 Chichkov,	 Two-photon	 polymerization	
technique	for	microfabrication	of	CAD-designed	3D	scaffolds	from	commercially	available	photosensitive	
materials,	J	Tissue	Eng	Regen	Med	1(6)	(2007)	443-9.	
[23]	 T.B.	 Woodfield,	 J.	 Malda,	 J.	 de	 Wijn,	 F.	 Peters,	 J.	 Riesle,	 C.A.	 van	 Blitterswijk,	 Design	 of	 porous	
scaffolds	 for	 cartilage	 tissue	 engineering	 using	 a	 three-dimensional	 fiber-deposition	 technique,	
Biomaterials	25(18)	(2004)	4149-61.	
[24]	 L.	Moroni,	 J.R.	 de	Wijn,	 C.A.	 van	 Blitterswijk,	 3D	 fiber-deposited	 scaffolds	 for	 tissue	 engineering:	
Influence	of	pores	geometry	and	architecture	on	dynamic	mechanical	properties,	Biomaterials	27	(2006)	
974-985.	
[25]	T.B.	Woodfield,	C.A.	Van	Blitterswijk,	J.	De	Wijn,	T.J.	Sims,	A.P.	Hollander,	J.	Riesle,	Polymer	scaffolds	
fabricated	 with	 pore-size	 gradients	 as	 a	 model	 for	 studying	 the	 zonal	 organization	 within	 tissue-
engineered	cartilage	constructs,	Tissue	Eng	11(9-10)	(2005)	1297-311.	
[26]	Y.	 Yan,	 Z.	Xiong,	Y.	Hu,	 S.	Wang,	R.	 Zhang,	C.	 Zhang,	 Layered	manufacturing	of	 tissue	engineering	
scaffolds	via	multi-nozzle	deposition,	Materials	Letters	57	(2003)	2623-2628.	
[27]	D.W.	Hutmacher,	K.W.	Ng,	C.	Kaps,	M.	Sittinger,	S.	Klaring,	Elastic	cartilage	engineering	using	novel	
scaffold	architectures	in	combination	with	a	biomimetic	cell	carrier,	Biomaterials	24(24)	(2003)	4445-58.	
[28]	 J.T.	 Schantz,	 A.	 Brandwood,	 D.W.	 Hutmacher,	 H.L.	 Khor,	 K.	 Bittner,	 Osteogenic	 differentiation	 of	
mesenchymal	progenitor	cells	 in	computer	designed	 fibrin-polymer-ceramic	 scaffolds	manufactured	by	
fused	deposition	modeling,	Journal	of	materials	science.	Materials	in	medicine	16(9)	(2005)	807-19.	
[29]	M.E.	Hoque,	D.W.	Hutmacher,	W.	Feng,	S.	Li,	M.H.	Huang,	M.	Vert,	Y.S.	Wong,	Fabrication	using	a	
rapid	prototyping	system	and	in	vitro	characterization	of	PEG-PCL-PLA	scaffolds	for	tissue	engineering,	J	
Biomater	Sci	Polym	Ed	16(12)	(2005)	1595-610.	
[30]	J.P.	Li,	J.R.	de	Wijn,	C.A.	Van	Blitterswijk,	K.	de	Groot,	Porous	Ti(6)Al(4)V	scaffold	directly	fabricating	
by	rapid	prototyping:	Preparation	and	in	vitro	experiment,	Biomaterials		(2005).	
[31]	 S.	Michna,	W.	Wu,	 J.A.	 Lewis,	 Concentrated	 hydroxyapatite	 inks	 for	 direct-write	 assembly	 of	 3-D	
periodic	scaffolds,	Biomaterials	26(28)	(2005)	5632-9.	
[32]	J.A.	Hubbell,	Hydrogel	systems	for	barriers	and	local	drug	delivery	in	the	control	of	wound	healing,	J	
Control	Release	39	(1996)	305-313.	
[33]	W.	Schuurman,	V.	Khristov,	M.W.	Pot,	P.R.	van	Weeren,	W.J.	Dhert,	J.	Malda,	Bioprinting	of	hybrid	
tissue	constructs	with	tailorable	mechanical	properties,	Biofabrication	3(2)	(2011)	021001.	
[34]	 F.	 Pati,	 J.	 Jang,	 D.H.	 Ha,	 S.	 Won	 Kim,	 J.W.	 Rhie,	 J.H.	 Shim,	 D.H.	 Kim,	 D.W.	 Cho,	 Printing	 three-
dimensional	 tissue	analogues	with	decellularized	extracellular	matrix	bioink,	Nature	 communications	5	
(2014)	3935.	
[35]	 D.	 Puppi,	 C.	 Mota,	 M.	 Gazzarri,	 D.	 Dinucci,	 A.	 Gloria,	 M.	 Myrzabekova,	 L.	 Ambrosio,	 F.	 Chiellini,	
Additive	 manufacturing	 of	 wet-spun	 polymeric	 scaffolds	 for	 bone	 tissue	 engineering,	 Biomedical	
microdevices	14(6)	(2012)	1115-27.	
[36]	G.	Vozzi,	A.	Previti,	D.	De	Rossi,	A.	Ahluwalia,	Microsyringe-based	deposition	of	two-dimensional	and	
three-dimensional	polymer	scaffolds	with	a	well-defined	geometry	for	application	to	tissue	engineering,	
Tissue	Eng	8(6)	(2002)	1089-98.	
[37]	 A.	 Tirella,	 F.	 Vozzi,	 G.	 Vozzi,	 A.	 Ahluwalia,	 PAM2	 (piston	 assisted	 microsyringe):	 a	 new	 rapid	
prototyping	 technique	 for	 biofabrication	 of	 cell	 incorporated	 scaffolds,	 Tissue	 engineering.	 Part	 C,	
Methods	17(2)	(2011)	229-37.	
[38]	C.J.	Hansen,	R.	Saksena,	D.B.	Kolesky,	J.J.	Vericella,	S.J.	Kranz,	G.P.	Muldowney,	K.T.	Christensen,	J.A.	
Lewis,	High-throughput	printing	via	microvascular	multinozzle	arrays,	Adv	Mater	25(1)	(2013)	96-102.	
[39]	 J.	Zhu,	R.E.	Marchant,	Design	properties	of	hydrogel	 tissue-engineering	scaffolds,	Expert	 review	of	
medical	devices	8(5)	(2011)	607-26.	
[40]	C.	De	Maria,	A.	De	Acutis,	G.	Vozzi,	 Indirect	Rapid	Prototyping	for	Tissue	Engineering,	Essentials	of	
3D	Biofabrication	and	Translation	(Elsevier	Inc.,	2015).		(2015).	
[41]	 R.	 Liska,	 F.	 Schwager,	 C.	Maier,	 R.	 Cano-Vives,	 J.	 Stampfl,	Water-soluble	 photopolymers	 for	 rapid	
prototyping	of	cellular	materials,	J	Appl	Polym	Sci	97(6)	(2005)	2286-2298.	
[42]	 J.Y.	 Tan,	 C.K.	 Chua,	 K.F.	 Leong,	 Indirect	 fabrication	 of	 tissue	 engineering	 scaffolds	 using	 rapid	
prototyping	and	a	 foaming	process,	 Innovative	Developments	 in	Design	and	Manufacturing	 	 (2010)	51-
57.	
[43]	 E.	 Sachlos,	N.	 Reis,	 C.	Ainsley,	 B.	Derby,	 J.T.	 Czernuszka,	Novel	 collagen	 scaffolds	with	predefined	
internal	morphology	made	by	solid	freeform	fabrication,	Biomaterials	24(8)	(2003)	1487-97.	
[44]	S.	Bose,	J.	Darsell,	M.	Kintner,	H.	Hosick,	A.	Bandyopadhyay,	Pore	size	and	pore	volume	effects	on	
alumina	and	TCP	ceramic	scaffolds,	Mat	Sci	Eng	C-Bio	S	23(4)	(2003)	479-486.	
[45]	J.S.	Miller,	K.R.	Stevens,	M.T.	Yang,	B.M.	Baker,	D.H.	Nguyen,	D.M.	Cohen,	E.	Toro,	A.A.	Chen,	P.A.	
Galie,	 X.	 Yu,	 R.	 Chaturvedi,	 S.N.	 Bhatia,	 C.S.	 Chen,	 Rapid	 casting	 of	 patterned	 vascular	 networks	 for	
perfusable	engineered	three-dimensional	tissues,	Nature	materials	11(9)	(2012)	768-74.	
[46]	R.	 Landers,	U.	Hubner,	R.	Schmelzeisen,	R.	Mulhaupt,	Rapid	prototyping	of	 scaffolds	derived	 from	
thermoreversible	 hydrogels	 and	 tailored	 for	 applications	 in	 tissue	 engineering,	 Biomaterials	 23	 (2002)	
4437-47.	
[47]	W.	Schuurman,	P.A.	Levett,	M.W.	Pot,	P.R.	van	Weeren,	W.J.	Dhert,	D.W.	Hutmacher,	F.P.	Melchels,	
T.J.	Klein,	J.	Malda,	Gelatin-Methacrylamide	Hydrogels	as	Potential	Biomaterials	for	Fabrication	of	Tissue-
Engineered	Cartilage	Constructs,	Macromolecular	bioscience		(2013).	
[48]	N.E.	Fedorovich,	W.	Schuurman,	H.M.	Wijnberg,	H.J.	Prins,	P.R.	van	Weeren,	J.	Malda,	J.	Alblas,	W.J.	
Dhert,	 Biofabrication	 of	 osteochondral	 tissue	 equivalents	 by	 printing	 topologically	 defined,	 cell-laden	
hydrogel	scaffolds,	Tissue	engineering.	Part	C,	Methods	18(1)	(2012)	33-44.	
[49]	 C.B.	 Highley,	 C.B.	 Rodell,	 J.A.	 Burdick,	 Direct	 3D	 Printing	 of	 Shear-Thinning	 Hydrogels	 into	 Self-
Healing	Hydrogels,	Adv	Mater	27(34)	(2015)	5075-9.	
[50]	T.	Bhattacharjee,	S.M.	Zehnder,	K.G.	Rowe,	S.	Jain,	R.M.	Nixon,	W.G.	Sawyer,	T.E.	Angelini,	Writing	in	
the	granular	gel	medium,	Science	advances	1(8)	(2015)	e1500655.	
[51]	 T.J.	 Hinton,	 Q.	 Jallerat,	 R.N.	 Palchesko,	 J.H.	 Park,	 M.S.	 Grodzicki,	 H.J.	 Shue,	 M.H.	 Ramadan,	 A.R.	
Hudson,	 A.W.	 Feinberg,	 Three-dimensional	 printing	 of	 complex	 biological	 structures	 by	 freeform	
reversible	embedding	of	suspended	hydrogels,	Science	advances	1(9)	(2015)	e1500758.	
[52]	G.	Villar,	A.D.	Graham,	H.	Bayley,	A	tissue-like	printed	material,	Science	340(6128)	(2013)	48-52.	
[53]	M.	Yanez,	 J.	 Rincon,	A.	Dones,	C.	De	Maria,	R.	Gonzales,	 T.	Boland,	 In	 vivo	assessment	of	printed	
microvasculature	in	a	bilayer	skin	graft	to	treat	full-thickness	wounds,	Tissue	engineering.	Part	A	21(1-2)	
(2015)	224-33.	
[54]	J.	Malda,	J.	Visser,	F.P.	Melchels,	T.	Jungst,	W.E.	Hennink,	W.J.	Dhert,	J.	Groll,	D.W.	Hutmacher,	25th	
anniversary	article:	Engineering	hydrogels	for	biofabrication,	Advanced	materials	25(36)	(2013)	5011-28.	
[55]	F.	Xu,	S.J.	Moon,	A.E.	Emre,	E.S.	Turali,	Y.S.	Song,	S.A.	Hacking,	J.	Nagatomi,	U.	Demirci,	A	droplet-
based	 building	 block	 approach	 for	 bladder	 smooth	muscle	 cell	 (SMC)	 proliferation,	 Biofabrication	 2(1)	
(2010)	014105.	
[56]	A.	Faulkner-Jones,	C.	Fyfe,	D.J.	Cornelissen,	 J.	Gardner,	 J.	King,	A.	Courtney,	W.	Shu,	Bioprinting	of	
human	 pluripotent	 stem	 cells	 and	 their	 directed	 differentiation	 into	 hepatocyte-like	 cells	 for	 the	
generation	of	mini-livers	in	3D,	Biofabrication	7(4)	(2015)	044102.	
[57]	 A.	 Faulkner-Jones,	 S.	 Greenhough,	 J.A.	 King,	 J.	 Gardner,	 A.	 Courtney,	W.	 Shu,	 Development	 of	 a	
valve-based	 cell	 printer	 for	 the	 formation	 of	 human	 embryonic	 stem	 cell	 spheroid	 aggregates,	
Biofabrication	5(1)	(2013)	015013.	
[58]	J.	Deitzel,	J.	Kleinmeyer,	D.	Harris,	N.	Beck	Tan,	The	effect	of	processing	variables	on	the	morphology	
of	electrospun	nanofibers	and	textiles,	Polymer	42	(2001)	261-272.	
[59]	 B.	 Carlberg,	 T.	Wang,	 J.	 Liu,	 Direct	 photolithographic	 patterning	 of	 electrospun	 films	 for	 defined	
nanofibrillar	microarchitectures,	Langmuir	26(4)	(2010)	2235-9.	
[60]	Y.	Wang,	G.	Wang,	L.	Chen,	H.	Li,	T.	Yin,	B.	Wang,	J.C.	Lee,	Q.	Yu,	Electrospun	nanofiber	meshes	with	
tailored	architectures	 and	patterns	 as	potential	 tissue-engineering	 scaffolds,	Biofabrication	1(1)	 (2009)	
015001.	
[61]	T.D.	Brown,	P.D.	Dalton,	D.W.	Hutmacher,	Direct	writing	by	way	of	melt	electrospinning,	Adv	Mater	
23(47)	(2011)	5651-7.	
[62]	 G.S.	 Bisht,	 G.	 Canton,	 A.	 Mirsepassi,	 L.	 Kulinsky,	 S.	 Oh,	 D.	 Dunn-Rankin,	 M.J.	 Madou,	 Controlled	
continuous	patterning	of	polymeric	nanofibers	on	three-dimensional	substrates	using	low-voltage	near-
field	electrospinning,	Nano	letters	11(4)	(2011)	1831-7.	
[63]	 S.N.	 Jayasinghe,	 A.N.	 Qureshi,	 P.A.M.	 Eagles,	 Electrohydrodynamic	 jet	 processing:	 An	 advanced	
electric-field-driven	jetting	phenomenon	for	processing	living	cells,	Small	2(2)	(2006)	216-219.	
[64]	S.L.	Sampson,	L.	Saraiva,	K.	Gustafsson,	S.N.	Jayasinghe,	B.D.	Robertson,	Cell	electrospinning:	an	in	
vitro	and	in	vivo	study,	Small	10(1)	(2014)	78-82.	
[65]	Y.	Ji,	K.	Ghosh,	B.	Li,	J.C.	Sokolov,	R.A.	Clark,	M.H.	Rafailovich,	Dual-syringe	reactive	electrospinning	
of	cross-linked	hyaluronic	acid	hydrogel	nanofibers	for	tissue	engineering	applications,	Macromolecular	
bioscience	6(10)	(2006)	811-7.	
[66]	 G.	 Jin,	 S.	 Lee,	 S.H.	 Kim,	 M.	 Kim,	 J.H.	 Jang,	 Bicomponent	 electrospinning	 to	 fabricate	 three-
dimensional	hydrogel-hybrid	nanofibrous	scaffolds	with	spatial	fiber	tortuosity,	Biomedical	microdevices		
(2014).	
[67]	 K.	 Jakab,	 A.	 Neagu,	 V.	 Mironov,	 R.R.	 Markwald,	 G.	 Forgacs,	 Engineering	 biological	 structures	 of	
prescribed	 shape	using	 self-assembling	multicellular	 systems,	 Proceedings	 of	 the	National	Academy	of	
Sciences	of	the	United	States	of	America	101(9)	(2004)	2864-9.	
[68]	K.	Jakab,	B.	Damon,	A.	Neagu,	A.	Kachurin,	G.	Forgacs,	Three-dimensional	tissue	constructs	built	by	
bioprinting,	Biorheology	43(3-4)	(2006)	509-13.	
[69]	K.	Jakab,	C.	Norotte,	B.	Damon,	F.	Marga,	A.	Neagu,	C.L.	Besch-Williford,	A.	Kachurin,	K.H.	Church,	H.	
Park,	V.	Mironov,	R.	Markwald,	G.	Vunjak-Novakovic,	G.	Forgacs,	Tissue	engineering	by	self-assembly	of	
cells	printed	into	topologically	defined	structures,	Tissue	engineering.	Part	A	14(3)	(2008)	413-21.	
[70]	J.M.	Kelm,	W.	Moritz,	D.	Schmidt,	S.P.	Hoerstrup,	M.	Fussenegger,	In	vitro	vascularization	of	human	
connective	microtissues,	Methods	Mol	Med	140	(2007)	153-66.	
[71]	F.	Marga,	K.	Jakab,	C.	Khatiwala,	B.	Shepherd,	S.	Dorfman,	B.	Hubbard,	S.	Colbert,	F.	Gabor,	Toward	
engineering	functional	organ	modules	by	additive	manufacturing,	Biofabrication	4(2)	(2012)	022001.	
[72]	D.G.	Nguyen,	J.	Funk,	J.B.	Robbins,	C.	Crogan-Grundy,	S.C.	Presnell,	T.	Singer,	A.B.	Roth,	Bioprinted	
3D	Primary	Liver	Tissues	Allow	Assessment	of	Organ-Level	Response	to	Clinical	Drug	Induced	Toxicity	In	
Vitro,	PloS	one	11(7)	(2016)	e0158674.	
[73]	D.	Murata,	S.	Tokunaga,	T.	Tamura,	H.	Kawaguchi,	N.	Miyoshi,	M.	Fujiki,	K.	Nakayama,	K.	Misumi,	A	
preliminary	 study	 of	 osteochondral	 regeneration	 using	 a	 scaffold-free	 three-dimensional	 construct	 of	
porcine	adipose	tissue-derived	mesenchymal	stem	cells,	Journal	of	orthopaedic	surgery	and	research	10	
(2015)	35.	
[74]	M.	 Itoh,	 K.	Nakayama,	R.	Noguchi,	 K.	 Kamohara,	 K.	 Furukawa,	K.	Uchihashi,	 S.	 Toda,	 J.	Oyama,	K.	
Node,	 S.	 Morita,	 Scaffold-Free	 Tubular	 Tissues	 Created	 by	 a	 Bio-3D	 Printer	 Undergo	 Remodeling	 and	
Endothelialization	when	Implanted	in	Rat	Aortae,	PloS	one	10(9)	(2015)	e0136681.	
[75]	O.	Frey,	P.M.	Misun,	D.A.	Fluri,	 J.G.	Hengstler,	A.	Hierlemann,	Reconfigurable	microfluidic	hanging	
drop	network	for	multi-tissue	interaction	and	analysis,	Nature	communications	5	(2014)	4250.	
[76]	 N.C.	 Rivron,	 E.J.	 Vrij,	 J.	 Rouwkema,	 S.	 Le	 Gac,	 A.	 van	 den	 Berg,	 R.K.	 Truckenmuller,	 C.A.	 van	
Blitterswijk,	Tissue	deformation	spatially	modulates	VEGF	signaling	and	angiogenesis,	Proceedings	of	the	
National	Academy	of	Sciences	of	the	United	States	of	America	109(18)	(2012)	6886-91.	
[77]	A.P.	Rago,	D.M.	Dean,	J.R.	Morgan,	Controlling	cell	position	in	complex	heterotypic	3D	microtissues	
by	tissue	fusion,	Biotechnology	and	bioengineering	102(4)	(2009)	1231-41.	
[78]	B.R.	Ringeisen,	H.	Kim,	J.A.	Barron,	D.B.	Krizman,	D.B.	Chrisey,	S.	Jackman,	R.Y.	Auyeung,	B.J.	Spargo,	
Laser	printing	of	pluripotent	embryonal	carcinoma	cells,	Tissue	Eng	10(3-4)	(2004)	483-91.	
[79]	 F.	 Guillemot,	 A.	 Souquet,	 S.	 Catros,	 B.	 Guillotin,	 Laser-assisted	 cell	 printing:	 principle,	 physical	
parameters	versus	cell	fate	and	perspectives	in	tissue	engineering,	Nanomedicine	5(3)	(2010)	507-15.	
[80]	R.	Devillard,	E.	Pages,	M.M.	Correa,	V.	Keriquel,	M.	Remy,	J.	Kalisky,	M.	Ali,	B.	Guillotin,	F.	Guillemot,	
Cell	patterning	by	laser-assisted	bioprinting,	Methods	in	cell	biology	119	(2014)	159-74.	
[81]	 J.	Yang,	M.	Yamato,	C.	Kohno,	A.	Nishimoto,	H.	Sekine,	F.	Fukai,	T.	Okano,	Cell	 sheet	engineering:	
recreating	tissues	without	biodegradable	scaffolds,	Biomaterials	26(33)	(2005)	6415-22.	
[82]	M.	Egami,	Y.	Haraguchi,	T.	Shimizu,	M.	Yamato,	T.	Okano,	Latest	status	of	the	clinical	and	industrial	
applications	of	cell	sheet	engineering	and	regenerative	medicine,	Archives	of	pharmacal	research	37(1)	
(2014)	96-106.	
[83]	N.	L'Heureux,	S.	Paquet,	R.	Labbe,	L.	Germain,	F.A.	Auger,	A	completely	biological	tissue-engineered	
human	 blood	 vessel,	 FASEB	 journal	 :	 official	 publication	 of	 the	 Federation	 of	 American	 Societies	 for	
Experimental	Biology	12(1)	(1998)	47-56.	
[84]	 J.G.	 Fernandez,	 A.	 Khademhosseini,	 Micro-masonry:	 construction	 of	 3D	 structures	 by	 microscale	
self-assembly,	Adv	Mater	22(23)	(2010)	2538-41.	
[85]	M.J.	 Hancock,	 F.	 Yanagawa,	 Y.H.	 Jang,	 J.	 He,	N.N.	 Kachouie,	 H.	 Kaji,	 A.	 Khademhosseini,	 Designer	
hydrophilic	regions	regulate	droplet	shape	for	controlled	surface	patterning	and	3D	microgel	synthesis,	
Small	8(3)	(2012)	393-403.	
[86]	 Y.	 Ling,	 J.	 Rubin,	 Y.	 Deng,	 C.	 Huang,	 U.	 Demirci,	 J.M.	 Karp,	 A.	 Khademhosseini,	 A	 cell-laden	
microfluidic	hydrogel,	Lab	on	a	chip	7(6)	(2007)	756-62.	
[87]	H.	Qi,	M.	Ghodousi,	Y.	Du,	C.	Grun,	H.	Bae,	P.	Yin,	A.	Khademhosseini,	DNA-directed	self-assembly	of	
shape-controlled	hydrogels,	Nature	communications	4	(2013)	2275.	
[88]	 S.	 Tasoglu,	 E.	 Diller,	 S.	 Guven,	 M.	 Sitti,	 U.	 Demirci,	 Untethered	 micro-robotic	 coding	 of	 three-
dimensional	material	composition,	Nature	communications	5	(2014)	3124.	
[89]	A.	Leferink,	D.	Schipper,	E.	Arts,	E.	Vrij,	N.	Rivron,	M.	Karperien,	K.	Mittmann,	C.	van	Blitterswijk,	L.	
Moroni,	 R.	 Truckenmuller,	 Engineered	micro-objects	 as	 scaffolding	elements	 in	 cellular	 building	blocks	
for	bottom-up	tissue	engineering	approaches,	Adv	Mater	26(16)	(2014)	2592-9.	
[90]	S.	 Zhao,	A.	Chen,	A.	Revzin,	T.	Pan,	Stereomask	 lithography	 (SML):	a	universal	multi-object	micro-
patterning	technique	for	biological	applications,	Lab	on	a	chip	11(2)	(2011)	224-30.	
[91]	 D.	 Huh,	 B.D.	Matthews,	 A.	Mammoto,	M.	Montoya-Zavala,	 H.Y.	 Hsin,	 D.E.	 Ingber,	 Reconstituting	
Organ-Level	Lung	Functions	on	a	Chip,	Science	328(5986)	(2010)	1662-1668.	
[92]	C.T.	Ho,	R.Z.	Lin,	R.J.	Chen,	C.K.	Chin,	S.E.	Gong,	H.Y.	Chang,	H.L.	Peng,	L.	Hsu,	T.R.	Yew,	S.F.	Chang,	
C.H.	 Liu,	 Liver-cell	 patterning	 lab	 chip:	mimicking	 the	morphology	 of	 liver	 lobule	 tissue,	 Lab	 on	 a	 chip	
13(18)	(2013)	3578-87.	
[93]	 Y.	 Imura,	 Y.	Asano,	K.	 Sato,	 E.	 Yoshimura,	A	microfluidic	 system	 to	evaluate	 intestinal	 absorption,	
Analytical	sciences	:	the	international	journal	of	the	Japan	Society	for	Analytical	Chemistry	25(12)	(2009)	
1403-7.	
[94]	C.	Franco,	H.	Gerhardt,	Tissue	engineering:	Blood	vessels	on	a	chip,	Nature	488(7412)	(2012)	465-6.	
[95]	M.K.	 Shin,	 S.K.	 Kim,	H.	 Jung,	 Integration	of	 intra-	 and	extravasation	 in	one	 cell-based	microfluidic	
chip	for	the	study	of	cancer	metastasis,	Lab	on	a	chip	11(22)	(2011)	3880-7.	
[96]	 H.	 Onoe,	 T.	 Okitsu,	 A.	 Itou,	M.	 Kato-Negishi,	 R.	 Gojo,	 D.	 Kiriya,	 K.	 Sato,	 S.	Miura,	 S.	 Iwanaga,	 K.	
Kuribayashi-Shigetomi,	 Y.T.	 Matsunaga,	 Y.	 Shimoyama,	 S.	 Takeuchi,	 Metre-long	 cell-laden	 microfibres	
exhibit	tissue	morphologies	and	functions,	Nature	materials	12(6)	(2013)	584-90.	
[97]	Y.	Morimoto,	A.Y.	Hsiao,	S.	Takeuchi,	Point-,	line-,	and	plane-shaped	cellular	constructs	for	3D	tissue	
assembly,	Advanced	drug	delivery	reviews	95	(2015)	29-39.	
[98]	 V.	 Mironov,	 T.	 Boland,	 T.	 Trusk,	 G.	 Forgacs,	 R.R.	 Markwald,	 Organ	 printing:	 computer-aided	 jet-
based	3D	tissue	engineering,	Trends	in	biotechnology	21(4)	(2003)	157-61.	
[99]	 W.C.	 Wilson,	 Jr.,	 T.	 Boland,	 Cell	 and	 organ	 printing	 1:	 protein	 and	 cell	 printers,	 The	 anatomical	
record.	Part	A,	Discoveries	in	molecular,	cellular,	and	evolutionary	biology	272(2)	(2003)	491-6.	
[100]	T.	Boland,	V.	Mironov,	A.	Gutowska,	E.A.	Roth,	R.R.	Markwald,	Cell	and	organ	printing	2:	fusion	of	
cell	 aggregates	 in	 three-dimensional	 gels,	 The	 anatomical	 record.	 Part	 A,	 Discoveries	 in	 molecular,	
cellular,	and	evolutionary	biology	272(2)	(2003)	497-502.	
[101]	D.J.	Odde,	M.J.	Renn,	Laser-guided	direct	writing	of	living	cells,	Biotechnology	and	bioengineering	
67(3)	(2000)	312-8.	
[102]	P.F.	Costa,	Biofabricated	constructs	as	tissue	models:	a	short	review,	Journal	of	materials	science.	
Materials	in	medicine	26(4)	(2015)	156.	
[103]	P.	Bajaj,	R.M.	Schweller,	A.	Khademhosseini,	 J.L.	West,	R.	Bashir,	3D	biofabrication	 strategies	 for	
tissue	engineering	and	regenerative	medicine,	Annual	review	of	biomedical	engineering	16	(2014)	247-
76.	
[104]	A.	Zargar,	G.F.	Payne,	W.E.	Bentley,	A	'bioproduction	breadboard':	programming,	assembling,	and	
actuating	cellular	networks,	Current	opinion	in	biotechnology	36	(2015)	154-60.	
[105]	B.D.	Liba,	E.	Kim,	A.N.	Martin,	Y.	Liu,	W.E.	Bentley,	G.F.	Payne,	Biofabricated	 film	with	enzymatic	
and	redox-capacitor	functionalities	to	harvest	and	store	electrons,	Biofabrication	5(1)	(2013)	015008.	
[106]	Z.F.	Bhat,	S.	Kumar,	H.F.	Bhat,	In	Vitro	Meat:	A	Future	Animal-Free	Harvest,	Critical	reviews	in	food	
science	and	nutrition		(2015)	0.	
[107]	C.	Cvetkovic,	R.	Raman,	V.	Chan,	B.J.	Williams,	M.	Tolish,	P.	Bajaj,	M.S.	Sakar,	H.H.	Asada,	M.T.	Saif,	
R.	Bashir,	Three-dimensionally	printed	biological	machines	powered	by	skeletal	muscle,	Proceedings	of	
the	National	Academy	of	Sciences	of	the	United	States	of	America	111(28)	(2014)	10125-30.	
[108]	E.A.	Corbin,	B.R.	Dorvel,	L.J.	Millet,	W.P.	King,	R.	Bashir,	Micro-patterning	of	mammalian	cells	on	
suspended	MEMS	 resonant	 sensors	 for	 long-term	 growth	measurements,	 Lab	 on	 a	 chip	 14(8)	 (2014)	
1401-4.	
[109]	J.R.	Tumbleston,	D.	Shirvanyants,	N.	Ermoshkin,	R.	Janusziewicz,	A.R.	Johnson,	D.	Kelly,	K.	Chen,	R.	
Pinschmidt,	 J.P.	 Rolland,	 A.	 Ermoshkin,	 E.T.	 Samulski,	 J.M.	 DeSimone,	 Additive	 manufacturing.	
Continuous	liquid	interface	production	of	3D	objects,	Science	347(6228)	(2015)	1349-52.	
[110]	 A.	 Blaeser,	 D.F.	 Duarte	 Campos,	M.	Weber,	 S.	 Neuss,	 B.	 Theek,	 H.	 Fischer,	W.	 Jahnen-Dechent,	
Biofabrication	under	fluorocarbon:	a	novel	freeform	fabrication	technique	to	generate	high	aspect	ratio	
tissue-engineered	constructs,	Biores	Open	Access	2(5)	(2013)	374-84.	
[111]	 A.	 Blaeser,	 D.F.	 Duarte	 Campos,	 U.	 Puster,	W.	 Richtering,	M.M.	 Stevens,	 H.	 Fischer,	 Controlling	
Shear	Stress	in	3D	Bioprinting	is	a	Key	Factor	to	Balance	Printing	Resolution	and	Stem	Cell	Integrity,	Adv	
Healthc	Mater	5(3)	(2016)	326-33.	
[112]	 C.S.	 O'Bryan,	 T.	 Bhattacharjee,	 S.	 Hart,	 C.P.	 Kabb,	 K.D.	 Schulze,	 I.	 Chilakala,	 B.S.	 Sumerlin,	W.G.	
Sawyer,	 T.E.	 Angelini,	 Self-assembled	 micro-organogels	 for	 3D	 printing	 silicone	 structures,	 Science	
advances	3(5)	(2017).	
[113]	C.S.	O’Bryan,	T.	Bhattacharjee,	S.R.	Niemi,	S.	Balachandar,	N.	Baldwin,	S.T.	Ellison,	C.R.	Taylor,	W.G.	
Sawyer,	T.E.	Angelini,	Three-dimensional	printing	with	sacrificial	materials	for	soft	matter	manufacturing,	
MRS	Bulletin	42(8)	(2017)	571-577.	
[114]	 D.B.	 Kolesky,	 R.L.	 Truby,	 A.S.	 Gladman,	 T.A.	 Busbee,	 K.A.	 Homan,	 J.A.	 Lewis,	 3D	 bioprinting	 of	
vascularized,	heterogeneous	cell-laden	tissue	constructs,	Advanced	materials	26(19)	(2014)	3124-30.	
[115]	V.K.	Lee,	D.Y.	Kim,	H.	Ngo,	Y.	Lee,	L.	Seo,	S.S.	Yoo,	P.A.	Vincent,	G.	Dai,	Creating	perfused	functional	
vascular	channels	using	3D	bio-printing	technology,	Biomaterials	35(28)	(2014)	8092-102.	
[116]	R.	Gaebel,	N.	Ma,	 J.	 Liu,	 J.	Guan,	L.	Koch,	C.	Klopsch,	M.	Gruene,	A.	Toelk,	W.	Wang,	P.	Mark,	F.	
Wang,	 B.	 Chichkov,	 W.	 Li,	 G.	 Steinhoff,	 Patterning	 human	 stem	 cells	 and	 endothelial	 cells	 with	 laser	
printing	for	cardiac	regeneration,	Biomaterials	32(35)	(2011)	9218-30.	
[117]	L.A.	Hockaday,	K.H.	Kang,	N.W.	Colangelo,	P.Y.C.	Cheung,	B.	Duan,	E.	Malone,	J.	Wu,	L.N.	Girardi,	
L.J.	 Bonassar,	 H.	 Lipson,	 C.C.	 Chu,	 J.T.	 Butcher,	 Rapid	 3D	 printing	 of	 anatomically	 accurate	 and	
mechanically	heterogeneous	aortic	valve	hydrogel	scaffolds,	Biofabrication	4(3)	(2012).	
[118]	P.J.	Besl,	N.D.	Mckay,	A	Method	 for	Registration	of	3-D	Shapes,	 Ieee	T	Pattern	Anal	14(2)	 (1992)	
239-256.	
[119]	 D.O.	 Freytes,	 R.S.	 Tullius,	 J.E.	 Valentin,	 A.M.	 Stewart-Akers,	 S.F.	 Badylak,	 Hydrated	 versus	
lyophilized	forms	of	porcine	extracellular	matrix	derived	from	the	urinary	bladder,	Journal	of	Biomedical	
Materials	Research	Part	A	87A(4)	(2008)	862-872.	
[120]	D.	Chimene,	K.K.	Lennox,	R.R.	Kaunas,	A.K.	Gaharwar,	Advanced	Bioinks	for	3D	Printing:	A	Materials	
Science	Perspective,	Ann	Biomed	Eng	44(6)	(2016)	2090-102.	
[121]	T.	Jungst,	W.	Smolan,	K.	Schacht,	T.	Scheibel,	J.	Groll,	Strategies	and	Molecular	Design	Criteria	for	
3D	Printable	Hydrogels,	Chem	Rev	116(3)	(2016)	1496-539.	
[122]	M.	Nakamura,	S.	Iwanaga,	C.	Henmi,	K.	Arai,	Y.	Nishiyama,	Biomatrices	and	biomaterials	for	future	
developments	of	bioprinting	and	biofabrication,	Biofabrication	2(1)	(2010)	014110.	
[123]	 A.	 Sydney	 Gladman,	 E.A.	 Matsumoto,	 R.G.	 Nuzzo,	 L.	 Mahadevan,	 J.A.	 Lewis,	 Biomimetic	 4D	
printing,	Nature	materials		(2016).	
[124]	S.	Tibbits,	4d	Printing:	Multi-Material	Shape	Change,	Archit	Design	84(1)	(2014)	116-121.	
[125]	C.G.	Simon,	Jr.,	M.J.	Yaszemski,	A.	Ratcliffe,	P.	Tomlins,	R.	Luginbuehl,	J.A.	Tesk,	ASTM	international	
workshop	 on	 standards	 and	 measurements	 for	 tissue	 engineering	 scaffolds,	 Journal	 of	 biomedical	
materials	research.	Part	B,	Applied	biomaterials	103(5)	(2015)	949-59.	
[126]	M.P.	Chhaya,	P.S.	 Poh,	 E.R.	Balmayor,	M.	 van	Griensven,	 J.T.	 Schantz,	D.W.	Hutmacher,	Additive	
manufacturing	in	biomedical	sciences	and	the	need	for	definitions	and	norms,	Expert	review	of	medical	
devices	12(5)	(2015)	537-43.	
[127]	 Y.P.	 Zhang,	 J.	 Sun,	 Y.	Ma,	 Biomanufacturing:	 history	 and	 perspective,	 J	 Ind	Microbiol	 Biotechnol	
44(4-5)	(2017)	773-784.	
[128]	G.	Hochleitner,	T.	Jungst,	T.D.	Brown,	K.	Hahn,	C.	Moseke,	F.	Jakob,	P.D.	Dalton,	J.	Groll,	Additive	
manufacturing	 of	 scaffolds	 with	 sub-micron	 filaments	 via	 melt	 electrospinning	 writing,	 Biofabrication	
7(3)	(2015)	035002.	
[129]	 C.	 Norotte,	 F.S.	Marga,	 L.E.	 Niklason,	 G.	 Forgacs,	 Scaffold-free	 vascular	 tissue	 engineering	 using	
bioprinting,	Biomaterials	30(30)	(2009)	5910-7.	
	
	 	
Glossary	of	main	terminology	to	be	used	in	the	biofabrication	field.		
Bio-engineered	structures:	Biological	constructs	engineered	by	using	in	a	pre-defined	manner	cells,	
biomaterials,	and/or	biological	factors	alone	or	in	combination	with	each	other.	
Bioink:	Formulation	of	material(s)	and	biological	molecules	/	cells	processed	using	bioprinting	
technologies.	
Biomaterials:	A	material	that	is	used	as	(part	of)	a	medical	device	or	an	advanced	therapy	medicinal	
product	to	replace,	restore,	or	regenerate	a	tissue	or	organ	and	its	function.		
Cell	spheroid:	A	cluster	of	cells,	with	a	spherical	shape,	typically	formed	by	allowing	cell	suspension	to	
settle	into	droplet	of	media.	
Electrospinning:	 A	 material	 processing	 technology	 that	 uses	 high	 electrical	 voltage	 to	 fabricate	 fine	
fibers	from	polymer	solution	or	molten	polymer.	Fibers	are	deposited	onto	a	collector,	with	a	random	or	
defined	alignment.	
Fabrication	 rate:	 Rate	 of	 fabrication	 of	 a	 scaffold	 or	 of	 a	 bioprinted	 construct	 using	 a	 biofabrication	
technology.	In	the	RTM,	it	can	be	calculated	as	the	time	to	fabricate	10
-6
	m
3
	(1	cm
3	
)cube,	lying	on	one	of	
its	faces.	
Fused	deposition	modelling	/	3D-fiber	deposition	/	bioextrusion:	Additive	manufacturing	technologies	
that	can	be	used	for	bioprinting,	in	which	a	thermoplastic	material,	in	shape	of	filament	or	pellet,	is	hot-
extrused	and	deposited	to	form	a	layer	of	solid	material.	Using	a	layer-by-layer	approach	a	3D	scaffold	or	
a	3D	construct	is	built.	
In-gel	printing:	3D	plotting	approach,	in	which	the	bioink	is	extruded	into	a	self-healing	gel	substrate,	
which	provides	mechanical	support.	
Indirect	additive	manufacturing:	A	biofabrication	approach	which	uses	an	additive	manufactured	mold	
in	which	a	bioink	is	casted,	injected	or	compressed.	
Ink-jet	and	valve-jet	bioprinting:	Printing	systems	able	to	bioprint	constructs	in	a	layer-by-layer	manner	
by	ejecting	bioinks	in	the	form	of	droplets	via	the	nozzle	head.	Droplet	ejection	is	controlled	either	by	
piezo-	or	thermal-actuators	(ink-jet),	or	by	solenoid	microvalves	(valve-jet).	
Laser	Induced	Forward	Transfer	(LIFT)	/	Laser	assisted	bioprinting	(LAB):	A	bioprinting	technique	which	
uses	laser	pulses	to	deposit	a	bioink	from	a	donor	slide	onto	a	substrate.	
Microfluidic	technology:	A	technology	based	on	geometrically	constrained	minute	volume	transport	in	
micro-channels.	This	technology	can	also	be	used	to	fabricate	strands	of	hydrogels,	suitable	as	building	
blocks	for	successive	assembling	processes.	
Micro-mansory	concept:	Biofabrication	approach	in	which	of	microunits	of	cell	laden	hydrogels	are	used	
as	regenerative	building	blocks.	
Minimum	feature	width:	Smallest	detail	that	can	be	fabricated	using	a	biofabrication	technology.	
3D	plotting	/	bioplotting	/	robotic	dispensing	/extrusion	bioprinting:	Bioprinting	technologies	that	
dispense	continuous	filament	of	hydrogel	materials,	extruded	through	a	nozzles	using	a	piston,	or	a	
screwing	system,	or	pneumatic	pressure	as	driving	force.	
Pressure-assisted	microsyringe	deposition	(PAM)	/	wet-spun	automated	extrusion	systems:	Additive	
manufacturing	technologies	that	can	be	used	for	bioprinting	based	on	the	extrusion	of	polymers	solved	
in	volatile	solvents.	The	quick	evaporation	of	the	solvent	allows	the	shape	retention	of	the	2D	pattern	
deposited	by	the	3D	micropositioner.	With	a	layer-by-layer	approach	a	3D	scaffold	can	be	fabricated.	
3D	printing:	An	additive	manufacturing	technology	that	can	be	used	for	bioprinting,	in	which	a	jet	of	
binder	is	directed	at	a	powder-bed	to	define	a	pattern.	The	solvent	binds	the	powder	forming	a	slice	of	
solid	material;	subsequently	a	new	layer	of	powder	is	laid	down	and	the	process	is	repeated	to	build	the	
scaffold	layer-by-layer.	
Resolution/time	of	manufacturing	(RTM)	ratio:	Figure	of	merit	to	classify	the	performance	of	
biofabrication	technologies,	defined	as	ratio	of	spatial	resolution	over	the	time	required	for	
biofabricating	a	bio-engineered	structure;		a	larger	RTM	represents	a	more	efficient	process.	
Scaffold-based	strategy:	A	biofabrication	approach	where	a	biomaterial	is	used	to	create	a	cell-laden	
scaffold	or	an	acellular	scaffold	with	hierarchical	ad/or	smart	surface	properties	able	to	steer	cell	activity	
and	regenerate	a	targeted	tissue.	
Scaffold-free	strategy:	A	Biofabrication	approach	where	a	biomaterial	is	eventually	only	used	as	a	
sacrificial	template	or	support	for	cells	to	be	deposited	and	let	organize	themselves	onto	it	for	the	
regeneration	of	a	targeted	tissue.	This	approach	comprises	also	the	deposition	of	cells	and/or	
biomolecules	only	with	no	biomaterial	support.	
Selective	laser	sintering:	An	additive	manufacturing	technology	that	can	be	used	for	bioprinting,	which	
uses	a	laser	whose	beam	of	light	is	selectively	directed	to	a	powder-bed,	generating	local	heat	and	
forming	patterns	of	fused	material;	after	its	solidification,	a	new	layer	of	powder	is	laid	down	and	the	
process	is	repeated	to	build	the	scaffold	layer-by-layer.	
Selective	laser	ablation:	An	additive	manufacturing	technology	that	can	be	used	for	bioprinting,	in	which	
a	solid	material	is	abladed	using	a	very	short	time	duration	laser	pulse.		If	the	ablation	process	is	
conducted	in	all	of	the	three	directions	or	if	laminated	porous	films	are	stacked	and	bonded	on	top	of	
each	other,	a	3D	structure	can	be	created.	
Stereolithography:	An	additive	manufacturing	technology	that	can	be	used	for	bioprinting,	in	which	light	
is	used	to	cure	a	photosensible	resin.	Although	different	irradiation	approaches,	the	various	
stereolithographic	systems	use	a	layer-by-layer	approach:	the	energy	delivered	by	the	light	is	sufficient	
to	solidify	a	certain	thickness	of	the	exposed	resin	and	join	this	layer	with	the	previous	one.					
Two-photon	polymerization:	Laser	based	technique	uses	near-infrared	ultrashort-pulsed	laser	to	excite	
in	a	precise	and	confine	space	molecules	(photoinitiators)	to	a	two-photon	state	triggering	the	
polymerization	of	monomers	in	solution.	This	was	the	first	technique	that	allowed	the	manufacturing	of	
true	3D	nano-/	micro-structures	without	supports.			
Tissue	liquidity:	The	notion,	introduced	by	Malcolm	Steinberg,	that	tissues	or	multicellular	aggregates	
composed	of	motile	and	adhesive	cells	have	properties	analogous	to	liquids,	evidenced	by	the	fact	that	
irregular	tissue	fragments	spontaneously	round	up	into	spheroids	and	two	fragments	composed	of	
different	cell	types	mutually	envelope	each	other.	Such	tissues	can	be	quantified	in	terms	of	apparent	
tissue	surface	tension.	
	
	 	
Table	1.	Summary	of	main	features	and	limitations	of	biofabrication	techniques.		
Technique	
RTM	ratio		
(10
-3
	m
2
/min)	
minimum	feature	
width	(	μm	=	10
-6
	m)	
Limitations	 References	
3Dä	Printing	 Medium	(~0.1)	 ~	300	
Presence	of	polymeric	grains	
and	of	excess	solvent.	
[6,	7]	
Selective	Laser	
Sintering	
Medium	to	high	
(~1)	
<	400	
Presence	of	polymeric	grains;		
limited	 to	 non-thermo-labile	
materials.	
[8-10]	
Laser	Ablation	
Medium	to	high	
(~1)	
<	400	
Thermo-labile	materials	(cells	
and	 proteins)	 can	 be	
damaged	 during	 scaffold	
fabrication.		
[12,	15]	
Stereolithograph
y	
Medium	(~0.5)	 ~	30-70	
Use	 of	 photo	 sensitive	
polymers	 and	 initiators,	
which	may	be	toxic.	
[18,	20]	
2-Photon	
Polymerization	
Medium	(~0.05)	 <	1	
Use	 of	 photo	 sensitive	
polymers	 and	 initiators,	
which	may	be	toxic.	
[21,	22]	
Digital	Light	
Processing	
Medium	to	high	
(~2)	
~	70	-	100	
Use	 of	 photo	 sensitive	
polymers	 and	 initiators,	
which	may	be	toxic.	
[19]	
Fused	Deposition	
Modeling	
Medium	to	high	
(~1)	
~	200	
Limited	 use	 with	 thermo-
labile	 materials.	 Evident	
layered	structure.	
[23-25]	
PAM	&	wet	spun	
technologies	
2
	
Medium	(~0.5)	 ~	20	
Limited	 range	 of	 material	
available	 and	 low	 vertical	
dimension	 processing	 time	
increasing	 with	 increasing	
the	 number	 of	 material	
heads	used.		
[35,	36]	
Indirect	Additive	
Manufacturing	
Low	(~0.03)	 ~	200	
Limited	mould	materials.		 [40-42]	
Bioplotting	 Medium	(~0.5)	 ~	100	
Need	 a	 self-sustaining	 gel	
(bioink)	showing	high	degree	
of	shear	thinning.	
[46-48]	
Ink-jet	
Bioprinting	
Medium	(~0.1)	 ~	100	
Limited	 range	 of	 gels	
(bioinks)	 available;	 inks	must	
be	of	low	viscosity.	
[52,	100]	
Valve-jet	
Bioprinting	
Medium	(~0.3)	 ~	200	
Delivery	 rate	 not	 sufficient	
for	building	clinically	relevant	
[56,	57]	
		 	
constructs	
Electrospinning	 Medium	(~0.1)	 <	1	
Difficult	 to	 realise	 thick	
scaffolds.	
	
Laser	Assisted	
Bioassembly	
Low	(~0.04)	 ~	30	
Difficult	 to	 realise	 thick	
scaffold;	limited	range	of	gels	
available.	
[78,	79]	
Bottom-up	
approaches	
Low	to	Very	Low	
(<0.001)	
~	30	
Long-time	 of	 fabrication	 due	
to	microunits	production	and	
construct	maturation.	
[81,	82]	
Figures	
	
	
Key	 Figure.	 Figure	 1:	 Distribution	 of	 various	 biofabrication	 technologies	 according	 to	 their	 minimum	
feature	width	(x-	axis)	and	printing	rate	(y-axis):	The	contour	lines	represents	the	RTM	ratio,	a	figure	of	
merit	 for	 classifying	 the	 biofabrication	 technologies	 according	 to	 their	 efficiency,	 taking	 into	 account	
resolution	and	fabrication	throughput.	A	larger	ratio	represents	a	more	efficient	process.	
	
	
	
	
	
	
	
	
	
	
	
	
	Figure	2.	Most	commonly	used	technologies	in	scaffold	based	biofabrication:	i)	Laser-based	technologies	
(selective	 laser	 sintering,	 stereolithography,	 two-photon	 polymerization);	 ii)	 3D	 printing;	 	 iii)	 fused	
deposition	modelling,	 iv)	 ink-jet	printing;	v)	3D	plotting;	vi)	 solution	and	melt	electrospinning.	Adapted	
from	[128]	with	permission.	
	
		
Figure	3.	Examples	of	 scaffold	 free	approaches:	extrusion	bioprinter	used	to	deposit	cell	aggregates	as	
spheroids	and/or	cylinders	 (a);	deposition	 strategy	 for	 fabricating	a	 straight	 (b)	or	branched	 (c)	hollow	
shape;	representation	of	cells	culture	on	thermos-responsive	culture	plates	(d)	and	cell-sheet	stacking	(e)	
as	steps	for	obtaining	a	complex	structure	(f)	in	a	cell-sheet	biofabrication	method.	Adapted	from	[129]	
and	[81]	with	permission.	
	
	
	
	
	
	
	
	Figure	 4.	 Scaffold	 free	 approach	 based	 on	 skewering	 of	 tissue	 spheroids:	 custom	 made	 device	 for	
automatic	 skewering	 (a);	 staking	 strategy	 for	obtaining	a	hollow	 shape	 (b);	 scaffold	 free	 vascular	 graft	
generated	from	mesenchymal	stem	cells	(c).	Adapted	from	[74]	with	permission.	
	
	
	
	
	Figure	 5.	 Examples	 of	 complex	 heterogeneous	 bioprinted	 structures.	 (a)	 bioprinting	 of	 shear-thinning	
supramolecular	 hydrogels	 into	 self-healing	 support	 gels	 allowing	 to	 manufacture	 continuously	 in	 3D	
space	while	patterning	of	multiple	inks	and	cells;	(b)	example	of	4D	printing	stimuli	responsive	materials	
that	 allow	 spatio-temporal	 changes	 (e.g.	 by	 swelling);	 (c)	 example	 of	 hierarchically	 branched	 tubular	
networks	printed	in	granular	gel	printing.		Adapted	from		with	permission	
	
